(ROOT
  (S
    (NP
      (NP
        (NP
          (NP
            (NP (NNP Optimisation))
            (PP (IN of)
              (NP
                (NP (DT the) (NN RT-PCR) (NN detection))
                (PP (IN of)
                  (NP
                    (ADJP (RB immunomagnetically) (JJ enriched))
                    (NN carcinoma) (NNS cells))))))
          (NP (NNP Abstract) (NNP Background)))
        (: :)
        (NP
          (NP (JJ Immunomagnetic) (NN enrichment))
          (VP (VBN followed)
            (PP (IN by)
              (NP (NN RT-PCR))))))
      (PRN (-LRB- -LRB-)
        (NP (JJ immunobead) (NN RT-PCR))
        (-RRB- -RRB-)))
    (VP (VBZ is)
      (NP (DT an) (JJ efficient) (NN methodology)
        (S
          (VP (TO to)
            (VP (VB identify)
              (NP (JJ disseminated) (NN carcinoma) (NNS cells))
              (PP (IN in)
                (NP (DT the) (NN blood)
                  (CC and)
                  (NN bone) (NN marrow))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN RT-PCR) (NNS assays))
    (VP (MD must)
      (VP (VB be)
        (ADJP (DT both)
          (ADJP (JJ specific)
            (PP (IN for)
              (NP (DT the) (NN tumor) (NNS cells))))
          (CC and)
          (ADJP (RB sufficiently) (JJ sensitive)))
        (S
          (VP (TO to)
            (VP (VB enable)
              (NP
                (NP (NN detection))
                (PP (IN of)
                  (NP (JJ single) (NN tumor) (NNS cells)))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBP have)
      (VP (VBN developed)
        (NP (DT a) (NN method)
          (S
            (VP (TO to)
              (VP (VB test)
                (NP (NN RT-PCR) (NNS assays))
                (PP (IN for)
                  (NP (DT any) (NN cancer)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT This))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN investigated)
          (S
            (VP (VBG using)
              (S
                (NP
                  (NP (DT a) (NN panel))
                  (PP (IN of)
                    (NP (NN RT-PCR) (NNS markers))))
                (ADJP (JJ suitable)
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN detection))
                      (PP (IN of)
                        (NP (NN breast) (NN cancer) (NNS cells))))))))))))
    (. .)))

(ROOT
  (FRAG
    (NP (NNS Methods))
    (: :)
    (S
      (PP (IN In)
        (NP (DT the) (NN assay)))
      (, ,)
      (NP
        (NP (DT a) (JJ single) (NN cell))
        (NP (JJ line-derived) (NN tumor) (NN cell)))
      (VP (VBZ is)
        (VP
          (VP (VBN added)
            (PP (TO to)
              (NP
                (NP (CD 100) (JJ peripheral) (NN blood) (NN mononuclear) (NNS cells))
                (PRN (-LRB- -LRB-)
                  (NP (NNP PBMNCs))
                  (-RRB- -RRB-))
                (SBAR
                  (WHPP (IN after)
                    (WHNP (WDT which)))
                  (S
                    (NP (NN mRNA))
                    (VP (VBZ is)
                      (ADJP (JJ isolated))))))))
          (CC and)
          (VP
            (ADVP (RB reverse))
            (VBN transcribed)
            (PP (IN for)
              (NP (NN RT-PCR) (NN analysis)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS PBMNCs))
      (PP (IN without)
        (NP (VBN added) (NN tumor) (NNS cells))))
    (VP (VBP are)
      (VP (VBN used)
        (PP (IN as)
          (NP (NN specificity) (NNS controls)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (DT The)
            (ADJP (RB previously)
              (NP (CD studied) (NNS markers))
              (JJ epidermal))
            (NN growth) (NN factor) (NN receptor))
          (PRN (-LRB- -LRB-)
            (NP (NNP EGFR))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NN mammaglobin) (CD 1))
          (PRN (-LRB- -LRB-)
            (NP (NNP MGB1))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (JJ epithelial) (NN cell) (NN adhesion) (NN molecule))
          (PRN (-LRB- -LRB-)
            (NP (NNP EpCAM/TACSTD1))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NN mucin) (CD 1))
          (PRN (-LRB- -LRB-)
            (NP (NNP MUC1))
            (-RRB- -RRB-)))
        (, ,)
        (ADJP (JJ carcinoembryonic) (JJ antigen)))
      (PRN (-LRB- -LRB-)
        (NP (NNP CEA))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN tested)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD Two) (JJ new) (JJ epithelial-specific) (NNS markers) (NN ELF3))
      (CC and)
      (NP (NNS EphB4)))
    (VP (VBD were)
      (VP
        (ADVP (RB also))
        (VBN tested)))
    (. .)))

(ROOT
  (NP
    (NP (NNS Results))
    (: :)
    (S
      (NP (NNP MUC1))
      (VP (VBD was)
        (ADJP (JJ unsuitable))
        (SBAR (IN as)
          (S
            (NP (JJ strong) (NN amplification))
            (VP (VBD was)
              (VP (VBN detected)
                (PP (IN in)
                  (NP (CD 100) (NN cell) (NN PBMNC) (NNS controls)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Expression))
      (PP (IN of)
        (NP (NNP ELF3) (, ,) (NNP EphB4) (, ,) (NNP EpCAM) (, ,) (NNP EGFR) (, ,) (NNP CEA)
          (CC and)
          (NNP MGB1))))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP (VB be)
              (ADJP (CC both)
                (ADJP (JJ specific)
                  (PP (IN for)
                    (NP (DT the) (NN tumor) (NN cell))))
                (PRN (, ,)
                  (SBAR (IN as)
                    (S
                      (S
                        (VP (VBN demonstrated)
                          (PP (IN by)
                            (NP
                              (NP (DT the) (NN absence))
                              (PP (IN of)
                                (NP
                                  (NP (DT a) (NN signal))
                                  (PP (IN in)
                                    (NP (RB most) (CD 100) (NN cell) (NNP PBMNC)))))))))
                      (VP (VBZ controls))))
                  (, ,))
                (CC and)
                (ADJP (JJ sensitive) (RB enough)
                  (S
                    (VP (TO to)
                      (VP (VB detect)
                        (NP (DT a) (JJ single) (NN tumor) (NN cell))
                        (PP (IN in)
                          (NP
                            (NP (CD 100) (NNS PBMNCs))
                            (VP (VBG using)
                              (NP
                                (NP (DT a) (JJ single) (NN round))
                                (PP (IN of)
                                  (NP (NN RT-PCR)))))))))))))))))
    (. .)))

(ROOT
  (NP
    (NP (NNS Conclusions))
    (: :)
    (NP
      (NP (NNP ELF3) (, ,) (NNP EphB4) (, ,) (NNP EpCAM) (, ,) (NNP EGFR) (, ,) (NNP CEA)
        (CC and)
        (NNP MGB1))
      (SBAR
        (S
          (VP (VBP are)
            (NP
              (NP (JJ appropriate) (NN RT-PCR) (NNS markers))
              (PP (IN for)
                (NP
                  (NP (NN use))
                  (PP (IN in)
                    (NP (DT a) (NN marker) (NN panel)))))
              (S
                (VP (TO to)
                  (VP (VB detect)
                    (NP (JJ disseminated) (NN breast) (NN cancer) (NNS cells))
                    (PP (IN after)
                      (NP (JJ immunomagnetic) (NN enrichment)))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Background))
    (VP (VBP Reverse)
      (SBAR
        (S
          (NP
            (NP (JJ transcriptase-polymerase) (NN chain) (NN reaction))
            (PRN (-LRB- -LRB-)
              (NP (NNP RT-PCR))
              (-RRB- -RRB-))
            (NNS assays))
          (VP (VBP have)
            (VP (VBN been)
              (VP (VBN developed)
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN detection))
                    (PP (IN of)
                      (NP (JJ disseminated) (NN carcinoma) (NNS cells)))))
                (PP (IN by)
                  (S
                    (VP (VBG targeting)
                      (NP (JJ epithelial)
                        (CC or)
                        (NN tumor) (JJ specific) (NN mRNA))
                      (PP (IN in)
                        (NP
                          (NP
                            (NP (NN bone) (NN marrow))
                            (, ,)
                            (NP (JJ peripheral) (NN blood))
                            (, ,)
                            (CC or)
                            (NP (NN lymph) (NNS nodes)))
                          (PRN (-LRB- -LRB-)
                            (VP (VBN reviewed)
                              (PP (IN in)
                                (NP
                                  (QP (CD -LSB-) (CD 1))
                                  (NNS -RSB-))))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (NP (NNS limitations))
    (VP (MD may)
      (VP (VB arise)
        (PP (IN from)
          (NP (JJ deficient) (NN expression)))
        (PP (IN in)
          (S
            (VP (VBG circulating)
              (NP
                (NP (NN tumor) (NNS cells))
                (CC or)
                (NP (JJ low) (NN level) (JJ illegitimate) (NN expression)))
              (PP (IN in)
                (NP (JJ haematopoietic) (NNS cells))))))
        (, ,)
        (SBAR (RB particularly) (IN if)
          (S
            (NP (DT a) (JJ nested) (NNP PCR) (NN approach))
            (VP (VBZ is)
              (VP (VBN used)
                (NP
                  (QP (CD -LSB-) (CD 2-5))
                  (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD developed)
      (NP (DT an) (JJ immunobead-based) (NN technique))
      (PP (IN for)
        (NP
          (NP (DT the) (NN enrichment))
          (PP (IN of)
            (NP (JJ epithelial) (NNS cells)))))
      (S
        (VP (TO to)
          (VP (VB increase)
            (NP (DT the) (NN signal))
            (PP (TO to)
              (NP
                (NP (NN noise) (NN ratio))
                (PP (IN for)
                  (NP (NNP PCR)))))
            (PP (VBN based)
              (NP
                (NP (NNS protocols))
                (VP (VBG -LSB-)
                  (NP (CD 6) (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT This))
    (VP (VBD was)
      (VP
        (ADVP (RB subsequently))
        (VBN adapted)
        (PP (TO to)
          (NP (NN RT-PCR) (NN methodology)))
        (S
          (VP (VBG -LSB-)
            (NP (CD 7) (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR
          (S
            (NP (JJ immunobead) (NN RT-PCR))
            (VP (VBZ is)
              (PP (IN of)
                (NP (JJ sufficient) (NN sensitivity)))
              (S
                (VP (TO to)
                  (VP (VB identify)
                    (NP (CD 1) (NN tumor) (NN epithelial) (NN cell))
                    (PP (IN in)
                      (S
                        (NP
                          (NP (DT a) (NN background))
                          (PP (IN of)
                            (NP (CD 106) (NN blood) (NNS cells))))
                        (VP (VBG -LSB-)
                          (NP (CD 7,8) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT A) (JJ recent) (NN study))
    (VP
      (VP (VBD compared)
        (NP (JJ immunobead) (NN RT-PCR))
        (PP (IN with)
          (NP
            (NP (JJ regular) (NN RT-PCR))
            (VP (VBG using)
              (NP
                (NP (NNP CEA))
                (PP (IN as)
                  (NP (DT the) (NN marker))))
              (PP (IN for)
                (NP
                  (NP (NN colon) (NN cancer) (NNS cells))
                  (VP (VBN spiked)
                    (PP (IN into)
                      (NP (JJ normal) (NN blood) (NNS samples))))))))))
      (CC and)
      (VP (VBD confirmed)
        (SBAR (IN that)
          (S
            (NP (DT the) (JJ immunobead) (NN RT-PCR) (NN method))
            (VP (VBZ is)
              (ADJP (RBR more) (JJ sensitive)
                (CC and)
                (JJ specific))
              (SBAR (IN than)
                (S
                  (NP (DT the) (JJ regular) (NN RT-PCR) (NN method))
                  (VP (VBZ -LSB-)
                    (NP (CD 9) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (QP (IN Up) (TO to) (CD 100))
        (JJ peripheral) (NN blood) (NNS leukocytes))
      (PRN (-LRB- -LRB-)
        (NP (NNP PBLs))
        (-RRB- -RRB-)))
    (VP (MD may)
      (VP (VB be)
        (VP
          (ADVP (RB concurrently))
          (VBN isolated)
          (PP (IN with)
            (NP (DT the) (NN tumor) (NNS cells)))
          (PP (IN during)
            (NP
              (NP (DT the) (JJ immunobead) (NN method))
              (VP (VBG -LSB-)
                (NP (CD 10) (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB previously))
    (VP (VBD had)
      (NP
        (NP (JJ similar) (NNS levels))
        (PP (IN of)
          (NP (NNP PBL) (NN contamination)))))
    (. .)))

(ROOT
  (S
    (SBAR (RB Now) (IN that)
      (S
        (NP (PRP we))
        (VP
          (VP (VB carry)
            (PRT (RP out))
            (NP
              (NP (NNS incubations))
              (PP (IN at)
                (NP (CD 4) (NN °) (NNP C)))))
          (CC and)
          (VP (VB take)
            (PRT (RP off))
            (NP (DT the) (NN cell) (NNS pellets))
            (PP (IN from)
              (NP
                (NP (DT the) (NNS magnets))
                (PP (IN for)
                  (S
                    (VP (VBG washing))))))))))
    (, ,)
    (ADVP (RB considerably))
    (NP
      (QP (JJR fewer) (IN than) (CD 10))
      (NNS cells))
    (VP (VBP are)
      (ADJP (VBN isolated))
      (PRN (-LRB- -LRB-)
        (NP (JJ unpublished) (NNS observations))
        (-RRB- -RRB-)))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ is)
      (ADVP (RB nevertheless))
      (ADJP (JJ important)
        (S
          (VP (TO to)
            (VP (VB assess)
              (SBAR (IN whether)
                (S
                  (NP
                    (NP (DT this) (JJ small) (NN number))
                    (PP (IN of)
                      (NP (NNS cells))))
                  (VP (MD can)
                    (VP (VB lead)
                      (PP (TO to)
                        (NP
                          (NP (JJ false) (NNS positives))
                          (ADJP (JJ due)
                            (PP (TO to)
                              (NP (JJ illegitimate) (NN expression)))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN paper)))
    (, ,)
    (NP (PRP we))
    (VP (VB introduce)
      (NP
        (NP (DT a) (JJ new) (NN strategy))
        (PP (IN for)
          (NP
            (NP (DT the) (NN testing))
            (PP (IN of)
              (NP
                (NP (NN RT-PCR) (NNS assays))
                (VP (VBG using)
                  (NP
                    (NP (DT a) (NN method))
                    (SBAR
                      (WHPP (IN in)
                        (WHNP (WDT which)))
                      (S
                        (NP (DT a) (JJ single) (NN tumor) (NN cell))
                        (VP (VBZ is)
                          (ADJP (JJ mixed)
                            (PP (IN with)
                              (ADVP
                                (NP (CD 100) (NNS PBMNCs))
                                (RB prior))))
                          (S
                            (VP (TO to)
                              (VP (VB RT-PCR)
                                (NP (NN analysis))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD 100) (NNS PBMNCs))
      (PP (IN without)
        (NP (VBN added) (NN tumor) (NNS cells))))
    (VP (VBP are)
      (VP (VBN used)
        (PP (IN as)
          (NP (NN specificity) (NNS controls)))))
    (. .)))

(ROOT
  (S
    (NP (DT This) (NN method))
    (VP (VBZ has)
      (VP (VBN allowed)
        (NP
          (NP (DT the) (NN identification))
          (PP (IN of)
            (NP
              (NP (DT a) (NN panel))
              (PP (IN of)
                (NP
                  (NP (NN RT-PCR) (NNS markers))
                  (PP (IN of)
                    (NP (JJ sufficient) (NN sensitivity)
                      (CC and)
                      (NN specificity))))))))
        (PP (IN for)
          (NP (JJ immunobead) (NN RT-PCR)))))
    (. .)))

(ROOT
  (SINV
    (S
      (NP (DT This) (NN study))
      (VP (VBZ includes)
        (NP
          (NP (DT an) (NN assessment))
          (PP (IN of)
            (NP
              (NP (CD 2) (RB previously) (JJ untested) (NN markers) (NN ELF3))
              (PRN (-LRB- -LRB-)
                (VP
                  (ADVP (RB also))
                  (VBN known)
                  (PP (IN as)
                    (NP (NNP ESX))))
                (-RRB- -RRB-)))))))
    (VP (VBZ -LSB-)
      (NP
        (NP
          (NP (CD 11) (NNS -RSB-))
          (CC and)
          (NP (JJ EphB4) (VBG -LSB-) (CD 12) (NNS -RSB-)))
        (, ,)
        (CONJP (RB as) (RB well) (IN as))
        (NP (DT the)
          (ADJP (RB previously) (JJ studied))
          (NN markers) (NN mucin))))
    (NP
      (NP (CD 1))
      (PRN (-LRB- -LRB-)
        (NP (NNP MUC1))
        (-RRB- -RRB-))
      (, ,)
      (NP
        (NP
          (NP (JJ carcinoembryonic) (NN antigen))
          (PRN (-LRB- -LRB-)
            (NP (NNP CEA))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (JJ epidermal) (NN growth) (NN factor) (NN receptor))
          (PRN (-LRB- -LRB-)
            (NP (NNP EGFR))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (JJ epithelial) (NN cell) (NN adhesion) (NN molecule))
          (PRN (-LRB- -LRB-)
            (NP (NNP EpCAM))
            (-RRB- -RRB-)))
        (CC and)
        (NP
          (NP (NN mammaglobin) (CD 1))
          (PRN (-LRB- -LRB-)
            (NP (NNP MGB1))
            (-RRB- -RRB-))
          (NP (NNS markers)))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Whether)
      (S
        (NP (DT a) (NN RT-PCR))
        (VP (VBZ is)
          (ADJP (JJ useful)))))
    (VP (VBZ depends)
      (PP
        (CONJP (RB not) (JJ only))
        (PP (IN on)
          (NP
            (NP (DT the) (NN marker))
            (VP (VBN used))))
        (CONJP (CC but)
          (RB also))
        (PP (IN on)
          (NP
            (NP (DT the) (JJ assay) (NNS conditions))
            (PP (IN for)
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBP marker)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT A) (JJ useful) (NN marker))
    (VP (MD will)
      (VP (VB be)
        (NP
          (NP (DT both))
          (ADJP
            (ADJP (JJ sensitive) (RB enough)
              (S
                (VP (TO to)
                  (VP (VB enable)
                    (NP
                      (NP (NN detection))
                      (PP (IN of)
                        (NP (DT a) (JJ single) (NN tumor) (NN cell))))))))
            (CC and)
            (ADJP (JJ specific) (RB enough)
              (S
                (VP (TO to)
                  (VP (RB not) (VB be)
                    (VP (VBN amplified)
                      (PP (IN from)
                        (NP (NNP PBLs))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (SBAR (IN as)
      (S
        (NP (JJ immunomagnetic) (NN cell))
        (VP (VBZ isolates)
          (VP (VB have)
            (NP
              (ADJP (RB very) (JJ low))
              (NN contamination))
            (PP (IN by)
              (NP (NNP PBLs)))))))
    (, ,)
    (NP (PRP it))
    (VP (VBZ is)
      (ADJP (JJ desirable)
        (S
          (VP (TO to)
            (VP (VB check)
              (NP
                (NP (DT the) (NN possibility))
                (PP (IN of)
                  (NP
                    (NP (JJ illegitimate) (NN expression))
                    (PP (IN in)
                      (NP
                        (NP (DT the)
                          (ADJP (RB very) (JJ low))
                          (NN number))
                        (PP (IN of)
                          (NP (NNP PBLs)))))))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (VBP are)
                      (VP (VBN retained)
                        (PP (IN after)
                          (NP (DT an) (JJ immunobead) (NN harvest)))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB test)
          (NP
            (NP (DT both) (NN specificity)
              (CC and)
              (NN sensitivity))
            (PP (IN of)
              (NP (PRP$ our) (JJ chosen) (NNS markers)))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD developed)
      (NP
        (NP (DT an) (NN assay))
        (SBAR
          (WHPP (IN in)
            (WHNP (WDT which)))
          (S
            (NP (DT a) (JJ single) (NN tumor) (NN cell))
            (VP (VBZ is)
              (ADJP (JJ deposited)
                (PP (IN into)
                  (NP (DT a) (JJ microcentrifuge) (NN tube))))
              (S
                (VP (VBG containing)
                  (NP (CD 100) (JJ normal) (NNS PBMNCs)))))))))
    (. .)))

(ROOT
  (S
    (NP (CD 100) (NNS PBMNCs))
    (VP (VBD were)
      (VP (VBN chosen)
        (SBAR (IN as)
          (S
            (NP (PRP we))
            (VP (VBP believe)
              (SBAR (IN that)
                (S
                  (NP (DT this) (NN number))
                  (VP (VBZ covers)
                    (NP
                      (NP (DT the) (JJ maximum) (NN amount))
                      (PP (IN of)
                        (NP (NNP PBMNC) (NN contamination))))
                    (SBAR (IN that)
                      (S
                        (NP (PRP we)
                          (CC or)
                          (NNS others))
                        (VP (VBP are)
                          (ADJP (JJ likely)
                            (S
                              (VP (TO to)
                                (VP (VB encounter))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Methods) (NNP Peripheral) (NN blood))
    (VP (VBD was)
      (VP (VBN collected)
        (PP (IN from)
          (NP (NNS patients)))
        (PP (IN with)
          (NP
            (NP (NN polycythemia) (NN vera))
            (SBAR
              (WHNP (WP who))
              (S
                (VP (VBD presented)
                  (PP (IN for)
                    (NP (NN treatment)))
                  (PP (IN at)
                    (NP
                      (NP (DT The) (NNP Queen) (NNP Elizabeth) (NNP Hospital))
                      (, ,)
                      (NP (NNP Adelaide) (, ,) (NNP Australia)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Informed) (NN consent))
      (SBAR
        (S
          (VP (VBD was)
            (VP (VBN obtained)
              (PP (IN in)
                (NP (DT all) (NNS cases)
                  (CC and)
                  (NNS ethics) (NN approval))))))))
    (VP (VBD was)
      (VP (VBN obtained)
        (PP (IN from)
          (NP
            (NP (DT The) (NNP Queen) (NNP Elizabeth) (NNP Hospital) (NNP Ethics))
            (PP (IN of)
              (NP (NNP Human) (NNP Research) (NNP Committee)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Mononuclear) (NNS cells))
    (VP (VBD were)
      (VP
        (VP (VBN collected)
          (PP (IN by)
            (NP (NN centrifugation)))
          (PP (IN through)
            (NP (DT a) (NNP Ficoll) (NN gradient))))
        (, ,)
        (VP (VBN washed)
          (PP (IN with)
            (NP
              (NP (JJ phosphate-buffered) (NN saline))
              (PRN (-LRB- -LRB-)
                (NP (NNP PBS))
                (-RRB- -RRB-)))))
        (CC and)
        (VP (VBN counted)
          (S
            (VP (VBG using)
              (NP (DT a) (NN haemocytometer)))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT the) (NN course))
        (PP (IN of)
          (NP (DT this) (NN investigation)))))
    (, ,)
    (NP
      (NP (NNP PBMNCs))
      (PP (IN from)
        (NP (CD eight) (JJ different) (NNS patients))))
    (VP (VBD were)
      (VP (VBN used)))
    (. .)))

(ROOT
  (SINV
    (FRAG
      (NP
        (NP (DT The) (NN breast) (NN cancer) (NN cell) (NNS lines))
        (ADJP (JJ MDA-MB-453) (, ,) (JJ T47-D) (, ,) (JJ MDA-MB-468) (, ,) (JJ MCF-7))))
    (, ,)
    (VP (VBD were)
      (VP (VBN cultured)
        (PP (IN in)
          (NP
            (NP (NNP DMEM))
            (, ,)
            (NP
              (NP
                (NP
                  (QP (CD pH) (CD 7.4)))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Invitrogen))
                  (, ,)
                  (NP (NNP Carlsbad))
                  (, ,)
                  (NP (NNP CA))
                  (-RRB- -RRB-)))
              (VP (VBN supplemented)
                (PP (IN with)
                  (NP
                    (NP (CD 100) (JJ U/ml) (NN penicillin))
                    (, ,)
                    (NP (CD 100) (NN μg))
                    (PRN (: /)
                      (NP
                        (NP (NN ml) (NN streptomycin))
                        (, ,)
                        (NP (CD 160) (NN μg)))
                      (: /))
                    (NP
                      (NP (NNP ml) (NNP L-glutamine))
                      (CC and)
                      (NP (CD 10) (NN %)))))))))))
    (NP
      (NP (JJ heat-inactivated) (JJ fetal) (JJ bovine) (NN serum))
      (PRN (-LRB- -LRB-)
        (NP (NNP JRH) (NNP Biosciences))
        (, ,)
        (NP (NNP Lenexa))
        (, ,)
        (NP (NNP KS))
        (-RRB- -RRB-)))
    (PP (IN in)
      (NP (CD 75) (JJ cm2) (JJ vented) (NN tissue) (NN culture) (NNS flasks)))
    (PP (IN at)
      (NP
        (NP (CD 37) (NNP °) (NNP C))
        (PP (IN in)
          (NP (DT a)
            (ADJP (CD 5) (NN %))
            (NN CO2) (NN environment)))))
    (. .)))

(ROOT
  (S
    (NP (NNP Log) (NN phase) (NNS cells))
    (VP (VBD were)
      (VP (VBN collected)
        (PP (IN at)
          (NP
            (NP
              (QP (JJR less) (IN than) (CD 90))
              (NN %))
            (ADJP (JJ confluency)
              (PP (IN by)
                (NP
                  (NP (NN trypsin) (NN digestion)
                    (CC and)
                    (NN centrifugation))
                  (PP (IN for)
                    (NP
                      (NP (CD 5) (NN min))
                      (PP (IN at)
                        (NP (CD 1000) (NN rpm))))))))
            (, ,)
            (VP
              (VP (VBN resuspended)
                (PP (IN in)
                  (NP
                    (NP
                      (ADJP (JJ phosphate) (JJ buffered))
                      (NN saline))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP PBS))
                      (-RRB- -RRB-)))))
              (CC and)
              (VP (VBN counted)
                (S
                  (VP (VBG using)
                    (NP (DT a) (NN haemocytometer))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN cell) (NNS lines))
    (VP (VBD were)
      (VP (VBN purchased)
        (PP (IN from)
          (NP
            (NP (DT the) (NNP American) (NNP Type) (NNP Culture) (NNP Collection))
            (PRN (-LRB- -LRB-)
              (NP (NNP ATCC))
              (, ,)
              (NP (NNP Rockville))
              (, ,)
              (NP (NNP MD))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT A) (JJ dilute) (NN suspension))
      (PP (IN of)
        (NP (DT a) (NN cell) (NN line))))
    (VP (VBD was)
      (VP (VBN prepared)
        (PP (IN in)
          (NP
            (NP (NN calcium))
            (CC and)
            (NP (RB magnesium) (JJ free)
              (NP (NNP Dulbecco) (POS 's))
              (NNP PBS))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Single) (NNS cells))
    (VP (VBD were)
      (VP
        (VP (VBN visualised)
          (S
            (VP (VBG using)
              (NP (DT an) (JJ inverted) (NN phase) (NN microscope)))))
        (CC and)
        (VP (VBN selected)
          (PP (IN by)
            (S
              (VP (VBG using)
                (NP (DT a) (NN micropipette)
                  (S
                    (VP (TO to)
                      (VP (VB draw)
                        (PRT (RP up))
                        (NP
                          (NP (DT the) (NN cell))
                          (PP (IN in)
                            (NP (DT a) (CD 1) (NN μl) (NN volume))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN cell))
    (VP (VBD was)
      (VP (VBN deposited)
        (PP (IN into)
          (NP (DT a) (CD 0.5) (NN ml) (NN microcentrifuge) (NN tube)))
        (S
          (VP
            (VP (VBG containing)
              (NP
                (NP (CD 100) (JJ peripheral) (NN blood) (NN mononuclear) (NNS cells))
                (PP (IN in)
                  (NP
                    (NP (CD 1) (NN μl))
                    (PP (IN of)
                      (NP (NN calcium)))))))
            (CC and)
            (VP (VBG magnesium)
              (NP
                (NP (JJ free) (NNP Dulbecco) (POS 's))
                (NNP PBS)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Aliquots))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBD contained)
            (NP (CD 100) (NN mononuclear) (NNS cells))
            (ADVP (RB only))))))
    (VP (VBD were)
      (VP (VBN included)
        (PP (IN as)
          (NP
            (NP (NNS controls))
            (PP (IN for)
              (NP
                (NP (DT the) (NN specificity))
                (PP (IN of)
                  (NP (DT the) (NN RT-PCR)))))))))
    (. .)))

(ROOT
  (SINV
    (S
      (NP (DT The) (NN cell) (NN mixture))
      (VP (VBD was)
        (VP (VBN lysed)
          (PP (IN in)
            (NP
              (NP (DT a) (CD 15) (NN μl) (NN volume))
              (PP (IN of)
                (NP (NN solution)))))
          (S
            (VP (VBG containing)
              (NP (CD 0.3) (NN %)))))))
    (VP (VBP v/v)
      (NP (NNP Nonidet) (NNP P-40)))
    (NP
      (NP (NN detergent))
      (PRN (-LRB- -LRB-)
        (NP (NNP Sigma))
        (-RRB- -RRB-))
      (, ,)
      (NP
        (NP
          (NP
            (QP (CD 500) (CD ng))
            (JJ random) (NNS hexamers))
          (PRN (-LRB- -LRB-)
            (NP (NNP Pharmacia))
            (, ,)
            (NP (NNP Uppsala))
            (, ,)
            (NP (NNP Sweden))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NNP 20) (NNP U))
          (PP (IN of)
            (NP (NNP RNasin)))
          (PRN (-LRB- -LRB-)
            (NP (NNP Promega))
            (, ,)
            (NP (NNP Madison))
            (, ,)
            (NP (NNP WI))
            (-RRB- -RRB-)))
        (CC and)
        (NP (CD 10) (NN mM) (NNP DTT))))
    (. .)))

(ROOT
  (S
    (PP (VBG Following)
      (NP
        (NP (CD 70) (JJ °) (NNP C) (NN denaturation))
        (PP (IN for)
          (NP (CD 3) (NNS minutes)))))
    (, ,)
    (NP (JJ reverse) (NN transcription))
    (VP (VBD was)
      (VP (VBN initiated)
        (PP (IN by)
          (NP
            (NP (DT the) (NN addition))
            (PP (IN of)
              (NP
                (NP
                  (NP
                    (QP (CD 5) (CD ×)))
                  (NP (NNP First) (NNP Strand) (NNP Buffer)))
                (, ,)
                (NP
                  (NP
                    (QP (CD 200) (CD U)))
                  (PP (IN of)
                    (NP
                      (NP (NNP Superscript) (NNP II))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP Invitrogen))
                        (-RRB- -RRB-)))))
                (, ,)
                (NP
                  (NP (CD 0.5) (NN mM))
                  (PP (IN of)
                    (NP
                      (NP (DT each) (JJ deoxynucleotide) (NN triphosphate))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP Roche))
                        (, ,)
                        (NP (NNP Mannheim))
                        (, ,)
                        (NP (NNP Germany))
                        (-RRB- -RRB-)))))
                (, ,)
                (PP (IN with)
                  (NP
                    (NP (JJ Ultra-pure) (NN water))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Fisher) (NNP Biotech))
                      (, ,)
                      (NP (NNP Perth))
                      (, ,)
                      (NP (NNP Australia))
                      (-RRB- -RRB-))))))))
        (PP (TO to)
          (NP
            (NP (DT a) (JJ final) (NN volume))
            (PP (IN of)
              (NP (CD 30) (NN μl)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT The) (NN reaction))
      (VP (VBD was)
        (VP (VBN incubated)
          (PP (IN at)
            (NP
              (NP (CD 42) (NNP °) (NNP C))
              (PP (IN for)
                (NP (CD 50) (NNS minutes))))))))
    (, ,)
    (CC and)
    (S
      (ADVP (RB then))
      (NP (DT the) (JJ reverse) (NN transcriptase))
      (VP (VBD was)
        (VP (VBN inactivated)
          (PP (IN at)
            (NP
              (NP (CD 70) (NNP °) (NNP C))
              (PP (IN for)
                (NP (CD 10) (NNS minutes))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP (JJ reverse) (NN transcription)))
    (, ,)
    (NP
      (NP (CD 4) (NN μl))
      (PP (IN of)
        (NP (NN cDNA))))
    (VP (VBD was)
      (VP (VBN used)
        (PP (IN as)
          (NP
            (NP (DT the) (NN template))
            (PP (IN in)
              (NP
                (NP (DT a) (JJ single) (NN round))
                (PP (IN of)
                  (NP (NNP PCR) (NN amplification)))))))
        (PP (IN with)
          (NP
            (NP
              (NP (CD 200) (NN nM))
              (PP (IN of)
                (NP
                  (NP (DT each) (NN gene) (JJ specific) (NN primer) (NN pair))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD Table) (CD 1)))
                    (-RRB- -RRB-)))))
            (, ,)
            (NP
              (NP (CD 1) (NNS U))
              (PP (IN of)
                (NP
                  (NP (NNP Hot) (NNP Star) (NNP Taq))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Qiagen))
                    (, ,)
                    (NP (NNP Valencia))
                    (, ,)
                    (NP (NNP CA))
                    (-RRB- -RRB-)))))
            (, ,)
            (NP
              (QP (CD 2.5) (CD mM))
              (NNS MgCl2))
            (, ,)
            (CC and)
            (NP
              (NP
                (QP (CD 200) (CD μM)))
              (PP (IN of)
                (NP (DT each) (JJ deoxynucleotide) (NN triphosphate)))
              (, ,)
              (PP (IN in)
                (NP (DT the) (NNP supplied) (NNP PCR) (NN buffer))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Cycling) (NNS conditions))
    (VP (VBD included)
      (SBAR
        (S
          (NP
            (NP (DT an) (JJ initial) (NN denaturation) (NN step))
            (PP (IN at)
              (NP
                (NP (CD 95) (NNP °) (NNP C))
                (PP (IN for)
                  (NP
                    (NP (CD 15) (NNS minutes))
                    (, ,)
                    (ADVP (RB then)
                      (NP (CD 1) (NN minute))
                      (PP (IN at)
                        (NP
                          (NP (DT each))
                          (PP (IN of)
                            (NP (CD 94))))))
                    (NP
                      (NP
                        (NP (NNP °) (NNP C))
                        (, ,)
                        (NP (CD 66)))
                      (: --)
                      (NP
                        (NP (CD 68) (JJ °) (NNP C)
                          (CC and)
                          (CD 72) (NN °) (NNS C))
                        (PP (IN for)
                          (NP (CD 45))))
                      (: --)
                      (NP
                        (NP (CD 55) (NNS cycles))
                        (CC and)
                        (NP
                          (NP (DT a) (JJ final) (NN extension))
                          (PP (IN of)
                            (NP
                              (NP (CD 7) (NNS minutes))
                              (PP (IN at)
                                (NP (CD 72) (NNP °) (NNP C.) (NNP Amplification) (NNS products)))))))))))))
          (VP (VBD were)
            (VP (VBN visualised)
              (PP (IN by)
                (NP (NN ethidium) (NN bromide)))
              (S
                (VP (VBG staining)
                  (NP (JJ following) (NN separation))
                  (PP (IN by)
                    (NP (NNS electrophoresis)))
                  (PP (IN through)
                    (NP (JJ agarose) (NNS gels))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT each) (NN case)))
    (NP
      (NP (DT an) (NNP RT) (JJ negative) (NN control))
      (, ,)
      (VP
        (VP (VBN made)
          (PRT (RP up))
          (PP (IN of)
            (NP
              (NP (DT the) (NNS components))
              (PP (IN of)
                (NP (DT the) (NNP RT) (NN reaction) (NN mixture)))))
          (PP (IN with)
            (CC or)
            (IN without)
            (NP (JJ lysis) (NN mix))))
        (, ,)
        (CC and)
        (VP
          (PP (IN without)
            (NP
              (NP (DT the) (NN addition))
              (PP (IN of)
                (NP (NNP RNA)))))))
      (, ,))
    (VP (VBD was)
      (VP (VBN used)
        (PP (IN as)
          (NP
            (NP (DT the) (NN template))
            (PP (IN in)
              (NP (DT the) (NNP PCR) (NN reaction)))
            (PRN (-LRB- -LRB-)
              (S
                (S
                  (NP (DT no) (NN cDNA))
                  (VP (VBD made)))
                (CC and)
                (S
                  (ADVP (RB therefore))
                  (NP (DT no) (NN amplification))
                  (VP (VBD expected))))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNP PCR) (JJ negative) (NN control))
    (VP
      (VP (VBZ contains)
        (NP
          (NP (DT the) (NNS reagents))
          (PP (IN of)
            (NP (DT the) (NNP PCR) (NN reaction)))))
      (CC but)
      (VP (VBZ lacks)
        (NP (NN template))))
    (. .)))

(ROOT
  (S
    (NP (JJ Cell) (NN line) (NN cDNA))
    (VP (VBD was)
      (VP (VBN included)
        (PP (IN as)
          (NP
            (NP (DT a) (JJ positive) (NN control))
            (PP (IN for)
              (NP (DT the) (NNP PCR) (NN reaction)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Genomic) (NNP DNA))
      (PRN (-LRB- -LRB-)
        (NP
          (QP (CD 100) (CD ng)))
        (-RRB- -RRB-)))
    (VP (VBD was)
      (VP (VBN used)
        (S
          (VP (TO to)
            (VP (VB confirm)
              (SBAR (IN that)
                (S
                  (NP
                    (NP (DT a) (NN product))
                    (PP (IN of)
                      (NP
                        (NP (JJ equal) (NN size))
                        (PP (TO to)
                          (NP (DT the) (NN cDNA) (NN product))))))
                  (VP (MD would) (RB not)
                    (VP (VB be)
                      (VP (VBN amplified)
                        (PP (IN from)
                          (NP
                            (NP (DT the) (NN DNA))
                            (PP (IN in)
                              (NP (DT the) (NN cell) (NN lysate)))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Results))
      (SBAR
        (S
          (NP
            (NP (DT The) (NN expression))
            (PP (IN of)
              (NP
                (NP (DT each))
                (PP (IN of)
                  (NP (DT the) (NN RT-PCR))))))
          (VP (VBZ markers)))))
    (VP (VBD was)
      (VP (VBN assessed)
        (PP (IN for)
          (NP (PRP$ its) (NN suitability)))
        (PP (IN as)
          (NP (DT a) (NN breast) (NN cancer) (NN marker)))))
    (. .)))

(ROOT
  (S
    (NP (NNP RNA))
    (VP (VBD was)
      (VP (VBN extracted)
        (PP (IN from)
          (NP
            (NP (CD seven) (NN breast) (NN cancer) (NN cell) (NNS lines))
            (, ,)
            (VP
              (ADVP (RB reverse))
              (VBN transcribed)
              (PP (IN into)
                (NP
                  (NP (NN cDNA))
                  (VP
                    (ADVP (RB then))
                    (VBN amplified)
                    (S
                      (VP (VBG using)
                        (NP
                          (NP (NNS primers))
                          (ADJP (JJ specific)
                            (PP (IN for)
                              (NP (DT the) (JJ different) (NNS markers))))
                          (PRN (-LRB- -LRB-)
                            (NP
                              (QP (CD Table) (CD 1)))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Transcripts) (NNP corresponding))
      (PP (TO to)
        (NP (NNP EpCAM))))
    (VP (VBD were)
      (VP (VBN amplified)
        (PP (IN from)
          (NP
            (NP (DT all))
            (PP (IN of)
              (NP
                (NP (DT the) (NN cell) (NNS lines))
                (VP (VBN tested)
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Fig.) (CD 1.))
                    (, ,)
                    (NP (NN panel) (CD 1))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT This))
      (VP (VBZ validates)
        (NP
          (NP (DT the) (NN use))
          (PP (IN of)
            (NP (NNS antibodies))))
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ recognise) (NNS epitopes))
              (PP (IN of)
                (NP
                  (NP (DT this) (NN protein))
                  (PP (IN as)
                    (NP
                      (NP (DT the) (JJ immunobead) (NN label))
                      (PP (IN for)
                        (NP
                          (NP (JJ magnetic) (NN isolation))
                          (PP (IN of)
                            (NP (DT the) (NN breast) (NN carcinoma) (NNS cells))))))))))
            (VP
              (VP (VBZ -LSB-)
                (NP (CD 6) (NNS -RSB-)))
              (CC and)
              (VP (VBZ confirms)
                (NP
                  (NP (JJR earlier) (NNS results))
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (VBD showed)
                        (NP
                          (NP
                            (NP (JJ uniform) (JJ bright) (NN fluorescence))
                            (PP (IN in)
                              (NP (NN breast) (NN cancer) (NN cell) (NNS lines))))
                          (CC and)
                          (NP
                            (NP (NNS biopsies))
                            (VP (VBN stained)
                              (PP (IN with)
                                (NP
                                  (NP (CD one))
                                  (PP (IN of)
                                    (NP (DT these) (NNS antibodies))))))))))))))))))
    (, ,)
    (NP (NNS Ber-Ep4))
    (VP (VBZ -LSB-)
      (NP (CD 7) (NNS -RSB-)))
    (. .)))

(ROOT
  (S
    (NP (NNP ELF3) (, ,) (NNP EphB4)
      (CC and)
      (NNP MUC1))
    (VP (VBD were)
      (VP (VBN amplified)
        (PP (IN in)
          (NP (DT all) (NN cell) (NNS lines)))
        (PP (IN at)
          (NP
            (NP
              (ADJP (RB consistently) (JJ high))
              (NNS levels))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP Fig.) (CD 1))
                (, ,)
                (NP (NNP panels) (CD 2) (, ,) (CD 3)
                  (CC and)
                  (CD 4)))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (JJ EGFR) (NN expression))
    (VP (VBD was)
      (ADVP (RB also))
      (ADJP
        (ADVP (RB easily))
        (JJ detectable)
        (PRN (-LRB- -LRB-)
          (NP (NNP Fig.) (CD 1))
          (, ,)
          (NP (NN panel) (CD 5))
          (-RRB- -RRB-)))
      (SBAR (RB even) (IN though)
        (S
          (NP (JJ several) (NNS reports))
          (VP (VBP have)
            (VP (VBN suggested)
              (SBAR
                (S
                  (NP (PRP it))
                  (VP
                    (VP (VBZ is)
                      (VP (VBN expressed)
                        (PP (IN at)
                          (NP
                            (NP (JJ low) (NNS levels))
                            (PP (IN in)
                              (NP (NN MCF-7)
                                (CC and)
                                (NN T47-D)))))))
                    (CC and)
                    (VP (VBZ is) (RB not)
                      (VP (VBN expressed)
                        (PP (IN in)
                          (NP (NNP MDA-MB-453) (NNP -LSB-) (CD 13,14) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP MGB1) (NNS transcripts))
      (VP (VBD were)
        (VP (VBN amplified)
          (PP (IN from)
            (NP (DT all) (NN cell) (NNS lines)))
          (PP (IN except)
            (PP (IN for)
              (NP
                (NP (NN MCF-7))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Fig.) (CD 1))
                  (, ,)
                  (NP (NN panel) (CD 2))
                  (-RRB- -RRB-))))))))
    (CC and)
    (S
      (NP (NNP CEA))
      (VP (VBD was)
        (VP (VBN amplified)
          (PP (IN from)
            (NP
              (NP (DT all) (NN cell) (NNS lines))
              (PP (IN except)
                (NP
                  (NP (NNP PMC42))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP Fig.) (CD 1))
                      (NP (NN panel) (CD 6)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Tubes))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBD contained)
            (NP
              (NP (CD 100) (NNS PBMNCs))
              (CC and)
              (NP (CD one) (NN tumor) (NN cell)))))))
    (VP (VBD were)
      (VP (VBN used)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (NN sensitivity))
                (PP (IN of)
                  (NP (DT each) (NN RT-PCR) (NN marker)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (JJS Most))
        (PP (IN of)
          (NP (DT the) (NN sensitivity) (NNS tests))))
      (VP (VBD were)
        (VP (VBN performed)
          (S
            (VP (VBG using)
              (NP (NN MDA-MB-453) (NNS cells)))))))
    (CC but)
    (S
      (NP (CD four) (JJ different) (NN breast) (NN cancer) (NN cell) (NNS lines))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN included)
            (PP (IN in)
              (NP
                (NP
                  (NP (DT this) (NN part))
                  (PP (IN of)
                    (NP (DT the) (NN study))))
                (, ,)
                (NP
                  (NP (CD two))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (VBP are)
                        (ADVP (RB ER))
                        (ADJP (JJ negative)))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP MDA-MB-453))
                    (, ,)
                    (NP (NNP and) (NNP MDA-MB-468))
                    (-RRB- -RRB-)))
                (CC and)
                (NP
                  (NP (CD two))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (VBP are)
                        (ADVP (RB ER))
                        (ADJP (JJ positive)))))
                  (PRN (-LRB- -LRB-)
                    (ADJP (JJ MCF-7)
                      (CC and)
                      (JJ T47-D))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBG Analysing)
        (NP
          (NP (DT the) (NNS samples))
          (SBAR
            (WHPP (TO to)
              (WHNP (WDT which)))
            (S
              (NP (DT a) (JJ single) (NN breast) (NN cancer) (NN cell))
              (VP (VBD had)
                (VP (VBN been)
                  (VP (VBN added)
                    (PP (TO to)
                      (NP
                        (QP (CD 100) (CD PBMNC))))))))))))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (PRP we))
          (VP (MD can)
            (VP (VB detect)
              (NP (DT the) (NN tumor) (NN cell))
              (ADVP (RBS most) (RB often))
              (PP (IN with)
                (NP
                  (NP
                    (NP (NNP ELF3))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 40/43))
                        (: --)
                        (NP (CD 93) (NN %)))
                      (-RRB- -RRB-)))
                  (CC and)
                  (NP
                    (NP
                      (NP (NNP EpCAM))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (CD 36/40))
                          (: --)
                          (NP (CD 89) (NN %)))
                        (-RRB- -RRB-)))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NNS Figures) (CD 2)
                          (CC and)
                          (CD 3))
                        (, ,)
                        (NP (NNS tables) (CD 2)
                          (CC and)
                          (CD 3)))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (SINV
    (VP (VBG EphB4)
      (NP (JJ specific) (NN amplification)))
    (VP (VBD detected))
    (NP
      (NP (CD 31/40))
      (PRN (-LRB- -LRB-)
        (NP (CD 77.5) (NN %))
        (-RRB- -RRB-))
      (, ,)
      (NP
        (NP
          (NP
            (QP (CD MUC1) (CD 10/20)))
          (PRN (-LRB- -LRB-)
            (NP (CD 67) (NN %))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NNP CEA) (CD 9/20))
          (PRN (-LRB- -LRB-)
            (NP (CD 45) (NN %))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NNP EGFR) (CD 19/43))
          (PRN (-LRB- -LRB-)
            (NP (CD 44) (NN %))
            (-RRB- -RRB-)))
        (CC and)
        (NP
          (NP
            (QP (CD MGB1) (CD 9/35)))
          (PRN (-LRB- -LRB-)
            (NP (CD 26) (NN %))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Tubes))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBD contained)
            (NP (CD 100) (NNS PBMNCs))
            (ADVP (RB only))))))
    (VP (VBD were)
      (VP (VBN included)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (NN specificity))
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD Table) (CD 2)))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (S
        (VP (VBG combining)
          (NP
            (NP (DT the) (NNS data))
            (VP (VBN obtained)
              (PP (IN from)
                (NP
                  (NP (JJ several) (JJ different) (NNS experiments))
                  (CC and)
                  (NP (JJ several) (JJ different) (JJ normal) (NNS individuals))))
              (PP (IN in)
                (NP
                  (NP (NNS reactions))
                  (VP (VBG using)
                    (NP
                      (NP (DT the) (JJ appropriate) (NN number))
                      (PP (IN of)
                        (NP (NN amplification) (NNS cycles))))))))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (NP
        (NP (DT no) (NN expression))
        (PP (IN of)
          (NP
            (NP
              (NP (NNP EGFR))
              (PRN (-LRB- -LRB-)
                (NP (CD 0/27))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NNP MGB1))
              (PRN (-LRB- -LRB-)
                (NP (CD 0/24))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NNS EphB4))
              (PRN (-LRB- -LRB-)
                (NP (CD 0/21))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NNP EpCAM))
              (PRN (-LRB- -LRB-)
                (NP (CD 0/21))
                (-RRB- -RRB-)))
            (CC or)
            (NP
              (NP
                (NP (NNP CEA))
                (PRN (-LRB- -LRB-)
                  (NP (CD 0/18))
                  (-RRB- -RRB-)))
              (, ,)
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNS Figures) (CD 2)
                    (CC and)
                    (CD 3))
                  (, ,)
                  (NP (NNP Table) (CD 2)))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S (RB Only)
    (NP (NNP ELF3)
      (CC and)
      (NNP MUC1))
    (VP (VBD gave)
      (NP (JJ positive) (NNS bands)))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBD were)
      (PP (IN for)
        (NP
          (NP (CD 45) (NNS cycles))
          (PP (IN of)
            (NP (NN amplification)))))
      (PP (IN except) (IN for)
        (NP
          (NP (NNP CEA))
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBD was)
                (VP (VBN run)
                  (PP (IN for)
                    (NP (CD 55) (NNS cycles))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB also))
    (VP (VBD examined)
      (NP (NNP ELF3) (, ,) (NNP EphB4)
        (CC and)
        (NNP MUC1))
      (PP (IN at)
        (NP (CD 55) (NNS cycles)))
      (PP (IN in)
        (NP
          (NP (DT a) (JJ small) (NN number))
          (PP (IN of)
            (NP (NNS experiments))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBN amplified)
      (NP
        (NP (NNS transcripts))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBD corresponded)
              (PP (TO to)
                (NP
                  (NP
                    (NP (NNP ELF3))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 1/6))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (NNS EphB4))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 3/12))
                      (-RRB- -RRB-)))
                  (CC and)
                  (NP
                    (NP (NNP MUC1))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 3/12))
                      (-RRB- -RRB-)))))
              (PP (IN in)
                (NP
                  (NP (DT some))
                  (PP (IN of)
                    (NP (DT the) (NNP PBMNC) (NN control) (NNS tubes))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNP ELF3)
      (CC and)
      (NNP EphB4) (NNS bands))
    (VP
      (VP (VBD were)
        (ADJP (JJ visible))
        (PP (VBG following)
          (NP
            (NP (NN ethidium) (NN bromide))
            (VP (VBG staining)))))
      (CC but)
      (VP (VBD were)
        (ADJP
          (ADJP (RBR less) (JJ intense))
          (SBAR (IN than)
            (S
              (NP
                (NP (DT the) (NN band))
                (VP
                  (VP (VBN amplified)
                    (PP (IN after)
                      (NP
                        (NP (DT the) (NN addition))
                        (PP (IN of)
                          (NP (DT a) (JJ single) (NN tumor) (NN cell))))))
                  (CC and)
                  (VP
                    (PP (IN in)
                      (NP (DT no) (NNS cases)))
                    (VBD were)
                    (NP
                      (NP
                        (QP (DT all) (CD three)))
                      (PP (IN of)
                        (NP (DT the) (NN PBMNC)))))))
              (VP (VBZ controls)
                (ADJP (JJ positive)
                  (PP (IN in)
                    (NP (DT the) (JJ same) (NN experiment))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBP assume)
      (SBAR (IN that)
        (S
          (NP (DT the) (NNP ELF3) (NN band))
          (VP (VBZ is)
            (NP
              (NP (DT a) (NN result))
              (PP (IN of)
                (NP
                  (NP (NN amplification))
                  (PP (IN of)
                    (NP (JJ illegitimate) (NNS transcripts))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT This) (NN band))
      (VP (VBD was)
        (VP (VBN eliminated)
          (SBAR
            (SBAR
              (WHADVP (WRB when))
              (S
                (NP
                  (NP
                    (QP (RB only) (CD 35))
                    (NNS cycles))
                  (PP (IN of)
                    (NP
                      (NP (NN amplification))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 0/15))
                        (-RRB- -RRB-)))))
                (VP (VBD were)
                  (VP (VBN performed)))))
            (CC but)
            (SBAR (IN because)
              (S
                (NP
                  (NP (RB only) (DT a) (JJ small) (NN amount))
                  (PP (IN of)
                    (NP (NN product))))
                (VP (VBD was)
                  (VP (VBN amplified)
                    (PP (IN after)
                      (NP
                        (NP
                          (QP (CD 45)
                            (CC or)
                            (CD 55))
                          (NNS cycles))
                        (PP (IN in)
                          (NP (DT these) (NNS controls)))))))))))))
    (NP (PRP we))
    (VP (MD could)
      (VP (VB distinguish)
        (NP
          (NP (NNS samples))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBD contained)
                (NP
                  (NP (NN tumor) (NNS cells))
                  (CC and)
                  (NP
                    (NP (DT those))
                    (SBAR
                      (WHNP (WDT that))
                      (S
                        (VP (VBD did)
                          (PP (RB not) (IN through)
                            (NP
                              (NP (NN comparison))
                              (PP (IN of)
                                (NP
                                  (NP (DT the) (NN intensity))
                                  (PP (IN of)
                                    (NP (NNS bands))))))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBG Analysing)
        (NP
          (NP (DT the) (NNS samples))
          (SBAR
            (WHPP (TO to)
              (WHNP (WDT which)))
            (S
              (NP (DT a) (JJ single) (NN breast) (NN cancer) (NN cell))
              (VP (VBD had)
                (VP (VBN been)
                  (VP (VBN added)
                    (PP (TO to)
                      (NP
                        (QP (CD 100) (CD PBMNC))))))))))))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (PRP we))
          (VP (MD could)
            (ADVP (RB still))
            (VP (VB detect)
              (NP (DT the) (NN tumor) (NN cell))
              (ADVP (RBS most) (RB often))
              (PP (IN with)
                (NP
                  (NP (NNP ELF3))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (CD 15/16))
                      (: --)
                      (NP (CD 94) (NN %)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Tests))
      (VP (VBG using)
        (NP (JJ single) (NN tumour) (NNS cells))
        (PP (IN in)
          (NP (DT a) (CD 100) (NN PBMNC) (NN background)))))
    (VP (VBD detected)
      (NP
        (NP
          (NP (CD 15/16))
          (PRN (-LRB- -LRB-)
            (NP (CD 94) (NN %))
            (-RRB- -RRB-)))
        (PP (IN of)
          (NP (NN tumour) (NNS cells))))
      (PP (IN after)
        (NP (CD 35) (NNS cycles))))
    (. .)))

(ROOT
  (S
    (PP (IN Unlike)
      (NP (NNP ELF3)))
    (, ,)
    (NP (DT the) (NNP MUC1) (NNP PBMNC) (NN band))
    (VP (VBD was)
      (PP (IN of)
        (NP (JJ comparable) (NN intensity)))
      (PP (TO to)
        (NP
          (NP (DT those))
          (VP (VBN achieved)
            (PP (IN after)
              (NP
                (NP (NN tumor) (NN cell) (NN addition))
                (VP (VBG making)
                  (S
                    (NP (PRP it))
                    (ADJP (JJ impossible)
                      (S
                        (VP (TO to)
                          (VP (VB distinguish)
                            (NP
                              (NP (NNS samples))
                              (SBAR
                                (WHNP (WDT that))
                                (S
                                  (VP (VBP contain)
                                    (NP (NN tumor) (NNS cells))
                                    (PP (IN from)
                                      (NP
                                        (NP (DT those))
                                        (SBAR
                                          (WHNP (WDT that))
                                          (S
                                            (VP (VBP do) (RB n't))))
                                        (PRN (-LRB- -LRB-)
                                          (NP (NN Figure) (CD 2))
                                          (-RRB- -RRB-))))))))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBN Discussion)
        (NP
          (NP (DT The) (NN development))
          (PP (IN of)
            (NP (JJ optimized) (NNS methods))))
        (PP (IN for)
          (S
            (VP (VBG detecting)
              (NP (NN tumor) (NNS cells))
              (PP (IN in)
                (NP
                  (NP (DT the) (JJ peripheral) (NN blood)
                    (CC and)
                    (NN bone) (NN marrow))
                  (PP (IN of)
                    (NP (NN cancer) (NNS patients))))))))))
    (VP (MD may)
      (VP (VB enhance)
        (NP (PRP$ our) (NN ability)
          (S
            (VP (TO to)
              (VP (VB identify)
                (NP (DT those) (NNS patients))
                (PP (IN in)
                  (NP
                    (NP (NN need))
                    (PP (IN of)
                      (NP (JJ further) (NN therapy)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Nested) (NNP RT-PCR))
      (PP (IN of)
        (NP (NNP PBMNCs))))
    (VP (VBZ has)
      (VP (VBN been)
        (NP (DT the)
          (ADJP (RBS most) (JJ common))
          (NN method)
          (S
            (VP (TO to)
              (VP (VB detect)
                (NP
                  (NP (NN epithelial))
                  (: --)
                  (NP (JJ specific) (NNS markers)))))))))
    (. .)))

(ROOT
  (S
    (PP (JJ Due) (TO to)
      (NP
        (NP (DT the) (JJ high) (NN level))
        (PP (IN of)
          (NP
            (NP (NN sensitivity))
            (PP (IN of)
              (NP (JJ nested) (NN RT-PCR)))))))
    (, ,)
    (NP
      (NP
        (ADJP (RB even) (JJ low))
        (NNS levels))
      (PP (IN of)
        (NP
          (NP (JJ illegitimate) (NN transcription))
          (PP (IN in)
            (NP (NNP PBMNCs))))))
    (VP (MD can)
      (VP (VB cause)
        (NP
          (NP (JJ false-positive) (NNS results))
          (VP (VBG -LSB-)
            (NP
              (QP (CD 2-5) (CD -RSB-)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP Nested) (NNP RT-PCR))
      (VP (VBZ is)
        (ADVP (RB also))
        (NP (JJR more) (NN time) (NN consuming))))
    (CC and)
    (S
      (NP (JJ stringent) (NNS procedures))
      (VP (VBP need)
        (S
          (VP (TO to)
            (VP (VB be)
              (VP (VBN observed)
                (PP (IN in)
                  (NP (NN order)))
                (S
                  (VP (TO to)
                    (VP (VB minimise)
                      (S
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (JJ false) (NNS positives))))
                        (ADJP (JJ due)
                          (PP (TO to)
                            (NP (NNP PCR) (NN product) (JJ cross) (NN contamination))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ is)
      (ADVP (RB thus))
      (ADJP (JJ desirable))
      (SBAR (IN that)
        (S
          (NP (DT the) (NN RT-PCR))
          (VP (VBZ is)
            (VP (VBN performed)
              (PP (IN in)
                (NP (DT a) (JJ single) (NN round)))
              (S
                (VP (TO to)
                  (VP (VB avoid)
                    (NP (JJ potential) (NN contamination) (NNS problems))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN use))
      (PP (IN of)
        (NP (JJ immunobead) (NN enrichment))))
    (ADVP (RB prior)
      (PP (TO to)
        (NP (JJ reverse) (NN transcription))))
    (VP (VBZ has)
      (VP (VBN allowed)
        (NP
          (NP (DT the) (NN use))
          (PP (IN of)
            (NP
              (NP (DT a) (JJ single) (NN round))
              (PP (IN of)
                (NP (NNP PCR) (NN amplification))))))
        (S
          (VP (TO to)
            (VP (VB screen)
              (NP (DT a) (JJ whole) (NN blood) (NN sample)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (PRP$ Our) (JJ original) (NN methodology))
      (VP (VBD used)
        (NP
          (NP (VBG blotting)
            (CC and)
            (NN detection))
          (PP (IN with)
            (NP (DT an)
              (ADJP (JJ oligonucleotide)
                (S
                  (VP (TO to)
                    (VP (VB increase)
                      (NP (NN sensitivity) (NNS -LSB-))))))
              (QP (CD 7) (CD -RSB-)))))))
    (CC but)
    (S
      (NP (DT this))
      (VP (VBZ is)
        (ADJP
          (ADVP (RB no) (RBR longer))
          (JJ necessary)
          (PP (IN with)
            (NP
              (NP (DT the)
                (ADJP (RBR more) (JJ efficient))
                (NN RT-PCR) (NNS assays))
              (VP (VBN presented)
                (ADVP (RB here))
                (, ,)
                (PP (IN in)
                  (NP
                    (NP (JJ particular))
                    (PP (RB because) (IN of)
                      (NP
                        (NP (DT the) (NN use))
                        (PP (IN of)
                          (NP (DT a) (JJ hot) (NN start) (NN Taq) (NN polymerase)))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB improve)
          (NP (NN RT-PCR) (NN detection))
          (ADVP (RBR further)))))
    (, ,)
    (NP
      (NP (DT the) (NN identification))
      (PP (IN of)
        (NP (NN epithelial)
          (CC or)
          (NN carcinoma) (NN cell) (JJ specific) (NNS markers)))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBP are)
            (VP (VBN expressed)
              (PP (IN at)
                (NP (DT a) (JJ sufficient) (NN level)))
              (S
                (VP (TO to)
                  (VP (VB enable)
                    (NP
                      (NP (NN detection))
                      (PP (IN of)
                        (NP (DT a) (JJ single) (NN cell))))
                    (PP (IN after)
                      (NP
                        (NP (RB only) (CD one) (NN round))
                        (PP (IN of)
                          (NP (JJ non-nested) (NNP PCR)))))))))))))
    (VP (VBP are)
      (VP (VBN needed)))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP (DT this) (NN reason)))
    (, ,)
    (NP (PRP we))
    (VP (VBP have)
      (VP (VBN used)
        (NP (JJ single) (NN tumor) (NNS cells))
        (PP (IN in)
          (NP
            (NP (DT a) (NN background))
            (PP (IN of)
              (NP (CD 100) (NNS PBMNCs)))))
        (S
          (VP (TO to)
            (VP (VB screen)
              (NP (CD seven) (JJ different) (NN RT-PCR) (NNS assays))
              (SBAR (IN in) (NN order)
                (S
                  (VP (TO to)
                    (VP (VB identify)
                      (NP
                        (NP (DT the) (JJS best) (NNS ones))
                        (PP (IN for)
                          (NP (NN inclusion))))
                      (PP (IN in)
                        (NP
                          (NP (DT a) (NN panel))
                          (PP (IN for)
                            (NP
                              (NP (DT the) (JJ immunobead) (NN RT-PCR))
                              (VP (VBN based)
                                (NP
                                  (NP (NN detection))
                                  (PP (IN of)
                                    (S
                                      (VP (VBG circulating)
                                        (NP (NN tumor) (NNS cells))))))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD used)
      (NP (NN breast) (NN cancer) (NN cell) (NNS lines))
      (PP (IN as)
        (NP
          (NP (DT the) (NN source))
          (PP (IN of)
            (NP (NN tumor) (NNS cells))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Whereas)
      (S
        (NP (NN breast) (NN cancer) (NN cell) (NNS lines))
        (VP (MD may)
          (VP (VB have)
            (NP
              (NP (JJ different) (NNS levels))
              (PP (IN of)
                (NP
                  (NP (NN expression))
                  (PP (IN of)
                    (NP
                      (NP (NNS markers))
                      (PP (VBN compared)
                        (PP (TO to)
                          (NP (JJ disseminated) (NN breast) (NN cancer) (NNS cells)))))))))))))
    (, ,)
    (NP
      (NP (NNS cells))
      (PP (IN from)
        (NP
          (NP (JJ different) (NNS individuals))
          (, ,)
          (CC and)
          (RB even) (IN within)
          (NP (DT an) (NN individual)))))
    (, ,)
    (VP (VBP are)
      (ADJP (JJ likely)
        (S
          (VP (TO to)
            (VP (VB display)
              (NP (JJ considerable) (NN heterogeneity)))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD sought)
      (S
        (VP (TO to)
          (VP (VB overcome)
            (NP (DT this) (NN difficulty))
            (PP (IN by)
              (S
                (VP (VBG using)
                  (NP
                    (NP (DT a) (NN number))
                    (PP (IN of)
                      (NP (NN cell) (NNS lines)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN use))
      (PP (IN of)
        (NP (NN cell) (NNS lines))))
    (VP (VBZ has)
      (NP
        (NP (DT the) (JJ great) (NN advantage))
        (PP (IN of)
          (S
            (VP (VBG providing)
              (NP (JJ reproducible) (NNS controls))
              (S
                (VP (TO to)
                  (VP (VB test)
                    (NP
                      (NP (DT the) (NN sensitivity))
                      (PP (IN of)
                        (NP (DT the) (NN RT-PCR) (NNS assays))))
                    (PP (IN during)
                      (NP
                        (NP (NNS studies))
                        (PP (IN of)
                          (NP (JJ patient) (NN material)))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ immunobead) (NN enrichment) (NN step))
    (VP (VBZ relies)
      (PP (IN on)
        (NP
          (NP (DT the) (NN expression))
          (PP (IN of)
            (NP
              (NP
                (NP (DT an) (JJ epithelial) (NN cell) (NN adhesion) (NN molecule))
                (PRN (-LRB- -LRB-)
                  (NP (NNP EpCAM))
                  (-RRB- -RRB-)))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (JJ current) (NN gene) (NN symbol))
                  (, ,)
                  (NP (NNP TACTSD1)))
                (, ,)
                (NP
                  (NP (JJ tumor-associated) (NN calcium) (NN signal) (NN transducer))
                  (NP (CD 1)))
                (-RRB- -RRB-))))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBZ is)
                (VP (VBN recognized)
                  (PP (IN by)
                    (NP
                      (NP (DT an) (NN antibody))
                      (PP (IN on)
                        (NP (NNS immunobeads))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD considered)
      (S
        (NP (DT this))
        (VP (TO to)
          (VP (VB be)
            (NP (DT an) (JJ appropriate) (JJ positive) (NN control))
            (, ,)
            (SBAR (IN as)
              (S
                (NP
                  (NP (DT any) (NN cell))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (VBZ is)
                        (VP (VBN detected)
                          (S
                            (VP (VBG using)
                              (NP (DT the) (NNS immunobeads)))))))))
                (VP (MD should)
                  (VP (VB express)
                    (NP (DT the) (NNP EpCAM) (NN gene))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT All))
      (PP (IN of)
        (NP (DT the) (NN breast) (NN cancer) (NN cell) (NNS lines))))
    (VP (VBD expressed)
      (SBAR
        (S
          (NP
            (NP (DT the) (NNP EpCAM) (NN gene))
            (CC and)
            (NP (DT no) (NN message)))
          (VP (VBD was)
            (VP (VBN detected)
              (PP (IN in)
                (NP
                  (NP (DT any))
                  (PP (IN of)
                    (NP
                      (NP (CD 24) (NNS aliquots))
                      (SBAR
                        (WHNP (WDT that))
                        (S
                          (VP (VBD contained)
                            (NP (CD 100) (NN PBMNC))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Tests))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ single) (NN tumor) (NN cell))
          (CC and)
          (NP
            (NP (CD 100) (NN PBMNC) (NNS aliquots))
            (PP (IN with)
              (NP (NNP EpCAM)))))))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (PRP it))
          (VP (VBD was)
            (VP
              (ADVP (RB also))
              (VBN expressed)
              (PP (TO to)
                (NP (DT a) (JJ sufficient) (NN level)))
              (S
                (VP (TO to)
                  (VP (VB enable)
                    (NP
                      (ADJP (JJ detection)
                        (PP (IN of)
                          (NP
                            (NP (DT the) (NN tumor) (NN cell))
                            (PP (IN in)
                              (NP
                                (NP (CD 31/35))
                                (PRN (-LRB- -LRB-)
                                  (NP (CD 89) (NN %))
                                  (-RRB- -RRB-)))))))
                      (NNS cases))
                    (PP (IN after)
                      (NP
                        (NP (CD 45) (NNS cycles))
                        (PP (IN of)
                          (NP (NNP PCR) (NN amplification)))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB therefore))
    (VP (VBP consider)
      (NP (NNP EpCAM))
      (NP
        (NP (DT a) (JJ useful) (NN addition))
        (PP (TO to)
          (NP
            (NP (DT a) (NN marker) (NN panel))
            (PP (IN for)
              (NP
                (NP (DT the) (NN detection))
                (PP (IN of)
                  (NP (NN breast) (NN tumor) (NNS cells)))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ is)
      (ADJP (JJ possible))
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN sensitivity))
            (PP (IN with)
              (NP (DT this) (NN marker))))
          (VP (MD can)
            (VP (VB be)
              (VP (VBN improved)
                (SBAR (IN if)
                  (S
                    (NP (JJR more) (NN PCR) (NNS cycles))
                    (VP (VBP are)
                      (VP (VBN performed)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Mucin) (CD 1))
      (PRN (-LRB- -LRB-)
        (NP (NNP MUC1))
        (-RRB- -RRB-)))
    (VP (VBZ is)
      (NP
        (NP (DT another) (JJ epithelial) (NN glycoprotein))
        (VP (VBN expressed)
          (PP (IN in)
            (NP (NN breast) (NN epithelial) (NNS cells))))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ is)
      (NP
        (NP (DT a)
          (ADJP (RB commonly) (VBN used))
          (ADJP (IN if) (JJ controversial))
          (NN marker))
        (PP (IN for)
          (NP
            (NP (NN detection))
            (PP (IN of)
              (S
                (VP (VBG circulating)
                  (NP (NN tumor) (NNS cells))
                  (S
                    (VP (VBG -LSB-)
                      (NP (CD 5) (NNS -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Recently))
    (, ,)
    (NP (PRP it))
    (VP (VBD was)
      (VP (VBN reported)
        (SBAR (IN that)
          (S
            (NP (DT that) (JJ immunomagnetic) (NN separation))
            (VP (VBD followed)
              (PP (IN by)
                (NP
                  (NP (JJ MUC1-specific) (JJ real) (NN time) (NN RT-PCR))
                  (VP (VBN allowed)
                    (NP
                      (NP (DT the) (JJ semi-quantitative) (NN detection))
                      (PP (IN of)
                        (S
                          (VP (VBG circulating)
                            (NP (JJ mammary) (NNS cells))
                            (SBAR (IN if)
                              (S
                                (NP
                                  (NP (NN amplification))
                                  (PP (IN above)
                                    (NP
                                      (NP (DT a) (NN cycle) (NN threshold) (NN value))
                                      (PP (IN of)
                                        (NP (CD 38))))))
                                (VP (VBD was)
                                  (VP (VBN obtained)
                                    (NP
                                      (QP (CD -LSB-) (CD 15))
                                      (NNS -RSB-))))))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBG Using)
        (NP (PRP$ our) (NN assay))))
    (, ,)
    (NP (NNP MUC1) (NNS transcripts))
    (VP (VBD were)
      (VP (VBN detected)
        (PP (IN in)
          (NP
            (NP
              (QP (CD 1/6) (CD 100))
              (NNP PBMNC) (JJ only) (NNS samples))
            (CC and)
            (NP (CD 10/15) (NN tumor) (NN cell) (NNS samples))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP (PRP we))
        (VP (VBD did) (RB not)
          (VP (VB use)
            (NP
              (NP (NNP real-time) (NNP PCR))
              (PP (IN for)
                (NP (PRP$ our) (NN assay))))))))
    (, ,)
    (S
      (NP
        (NP (DT the) (NN intensity))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ positive) (NNS bands))
            (PP (IN in)
              (NP (DT the) (JJ PBMNC) (JJ only) (NNS samples))))))
      (VP (VBD was)
        (ADJP (JJ comparable)
          (PP (TO to)
            (NP
              (NP (DT that))
              (VP (VBN obtained)
                (PP (IN with)
                  (NP (DT the) (NN tumor) (NN cell) (NNS samples)))))))))
    (CC and)
    (S
      (NP (PRP it))
      (VP (VBD was)
        (VP (VBN concluded)
          (SBAR (IN that)
            (S
              (NP
                (NP (NN detection))
                (PP (IN of)
                  (NP (CD MUC1) (NNS transcripts))))
              (VP (MD would)
                (VP (VB result)
                  (PP (IN in)
                    (NP
                      (ADJP (RB too) (JJ many))
                      (JJ false) (JJ positive) (NNS results)))
                  (S
                    (VP (TO to)
                      (VP (VB warrant)
                        (NP (PRP$ its) (NN inclusion))
                        (PP (IN in)
                          (NP (PRP$ our) (NN panel)))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (PP (IN during)
      (NP
        (NP (DT the) (NN course))
        (PP (IN of)
          (NP (DT this) (NN study)))))
    (NP (PRP it))
    (VP (VBD was)
      (VP (VBN reported)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT a) (NN majority))
              (PP (IN of)
                (NP
                  (NP
                    (NP (NNP CK))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP +))
                      (-RRB- -RRB-)))
                  (SBAR
                    (S
                      (NP
                        (NP
                          (ADJP
                            (QP (CD /) (CD MUC1)))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP +))
                            (-RRB- -RRB-))
                          (NN tumor) (NNS cells))
                        (VP (VBG circulating)
                          (PP (IN in)
                            (NP
                              (NP (DT the) (NN blood))
                              (PP (IN of)
                                (NP (NNS patients)))))
                          (PP (IN with)
                            (NP (JJ advanced) (NN breast) (NN cancer)))
                          (ADVP (RB also))))
                      (VP (VBD displayed)
                        (NP
                          (NP (JJ apoptotic) (NNS features))
                          (PP (JJ such) (IN as)
                            (NP
                              (NP (DT an) (`` ``) (NN inclusion) (NN type) ('' '') (NN cytokeratin))
                              (VP (VBG staining)
                                (NP
                                  (NP (NN pattern)
                                    (CC and)
                                    (JJ nuclear) (NN condensation))
                                  (PP (IN with)
                                    (NP (JJ apoptosis-related) (NN DNA))))))))))))))
            (VP (VBD strand)
              (SBAR
                (S
                  (NP (NNS breaks))
                  (VP (VBZ -LSB-)
                    (NP (CD 16) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBD was)
      (VP (VBN concluded)
        (SBAR (IN that)
          (S
            (NP
              (NP
                (NP (DT the) (JJ predictive) (NN value))
                (PP (IN of)
                  (NP (JJ such) (NNP CK))))
              (PRN (-LRB- -LRB-)
                (NP (NNP +))
                (-RRB- -RRB-)))
            (VP (VBD /)
              (SBAR
                (S
                  (NP (JJ MUC1)
                    (PRN (-LRB- -LRB-)
                      (NP (NNP +))
                      (-RRB- -RRB-))
                    (JJ positive) (NNS cells))
                  (VP (MD should)
                    (VP (VB be)
                      (VP (VBN considered)
                        (ADVP (RB separately))
                        (SBAR
                          (WHADVP (WRB when))
                          (S
                            (VP
                              (VP (VBG analysing)
                                (NP (NN tumor) (NN cell) (NN dissemination)))
                              (, ,)
                              (ADVP (RBR further))
                              (VP (VBG supporting)
                                (NP (PRP$ our) (NN decision))
                                (S (RB not)
                                  (VP (TO to)
                                    (VP (VB include)
                                      (NP (NNP MUC1)))))))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (JJ Elevated) (NNS levels))
        (PP (IN of)
          (NP (JJ serum) (JJ carcinoembryonic) (NN antigenCEA))))
      (VP (VBP are)
        (ADVP (RB commonly))
        (VP (VBN used)
          (PP (IN as)
            (NP
              (NP (DT a) (JJ clinical) (NN tool))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN diagnosis)
                    (CC and)
                    (NN monitoring))
                  (PP (IN of)
                    (NP (NNS metastasis))))))))))
    (CC but)
    (S
      (NP
        (NP (DT the) (NN use))
        (PP (IN of)
          (NP
            (NP (NNP CEA))
            (PP (IN as)
              (NP (DT an) (JJ immunobead) (NN RT-PCR) (NN marker))))))
      (VP (VBD -LSB-)
        (SBAR
          (S
            (NP (CD 17) (NNS -RSB-))
            (VP (VBZ has)
              (VP (VBN given)
                (NP (VBG varying) (NNS results))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP CEA))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN considered)
          (S
            (VP (TO to)
              (VP (VB show)
                (NP (DT no) (JJ diagnostic) (NN value))
                (PP (IN as)
                  (NP
                    (NP (DT a) (NN RT-PCR) (NN marker))
                    (PP (IN for)
                      (NP
                        (NP (DT the) (NN detection))
                        (PP (IN of)
                          (NP (NNS micrometastases)))))))
                (SBAR (IN because)
                  (S
                    (NP (PRP it))
                    (VP (VBZ is)
                      (VP (VBN expressed)
                        (PP (IN in)
                          (NP
                            (NP (DT the) (NN blood)
                              (CC and)
                              (NN lymph) (NNS nodes))
                            (PP (IN of)
                              (NP (NNS patients)))))
                        (PP (IN without)
                          (NP
                            (NP (NN cancer))
                            (VP (VBG -LSB-)
                              (NP (CD 5) (NNS -RSB-)))))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (PP (IN in)
      (NP
        (NP (DT a) (NN comparison))
        (PP (IN of)
          (NP (JJ immunobead) (NN RT-PCR)
            (CC and)
            (JJ regular) (NN RT-PCR) (NNS amplification)))))
    (, ,)
    (NP (PRP it))
    (VP (VBD was)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (JJ immunobead) (NN isolation))
            (VP (VBZ increases)
              (NP
                (NP (DT the) (NN specificity))
                (PP (IN of)
                  (NP (NNP CEA) (NNP -LSB-) (CD 8) (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBG Using)
        (NP (CD 55) (NNP PCR) (NNS cycles))
        (PP (IN for)
          (NP (NNP CEA)))))
    (, ,)
    (NP (PRP we))
    (VP
      (VP (VBD found)
        (NP (NN amplification))
        (PP (IN in)
          (NP
            (NP (NN none))
            (PP (IN of)
              (NP (DT the) (JJ PBMNC) (JJ only) (NNS samples))))))
      (CC and)
      (VP (VBD gained)
        (NP (DT a) (JJ positive) (NN result))
        (PP (IN for)
          (NP
            (NP (CD 45) (NN %))
            (PP (IN of)
              (NP
                (NP (DT the) (JJ single) (NN tumor) (NN cell) (NNS samples))
                (SBAR
                  (S
                    (NP (PRP we))
                    (VP (VBD tested))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Thus))
    (, ,)
    (NP (NNP CEA))
    (VP (VBZ appears)
      (S
        (VP (TO to)
          (VP (VB be)
            (NP (DT a)
              (ADJP (RB very) (JJ useful))
              (NN marker))
            (SBAR
              (WHADVP (WRB when))
              (S
                (NP (JJ immunobead) (NN enrichment))
                (VP (VBZ is)
                  (VP (VBN performed)
                    (PP (RB prior)
                      (PP (TO to)
                        (NP (NN RT-PCR))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Epidermal) (NN growth) (NN factor) (NN receptor))
      (PRN (-LRB- -LRB-)
        (NP (NNP EGFR))
        (, ,)
        (NP (NNP HER1))
        (, ,)
        (NP (NNP ErbB1))
        (-RRB- -RRB-)))
    (VP (VBZ is)
      (NP
        (NP (DT a) (JJ tyrosine) (NN kinase))
        (SBAR (WP$ whose)
          (S
            (NP (NN activation))
            (VP (VBZ plays)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (NP
                    (NP
                      (NP (DT the) (NN regulation))
                      (PP (IN of)
                        (NP (NN cell) (NN proliferation))))
                    (, ,)
                    (NP
                      (NP (NN differentiation)
                        (CC and)
                        (NN survival))
                      (PP (IN with)
                        (NP
                          (NP (DT a) (JJ pivotal) (NN role))
                          (PP (IN in)
                            (NP (NN maintenance))))))
                    (CC and)
                    (NP
                      (NP (NN repair))
                      (PP (IN of)
                        (NP (JJ epithelial) (NNS tissues))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP EGFR))
      (VP (VBZ is)
        (VP (VBN overexpressed)
          (PP (IN in)
            (NP (CD 50))))))
    (: --)
    (S
      (NP
        (NP (CD 70) (NN %))
        (PP (IN of)
          (NP (JJ human) (JJ primary) (NN breast) (, ,) (NN lung) (, ,)
            (CC and)
            (NN colon) (NNS carcinomas))))
      (VP (VBZ -LSB-)
        (NP (CD 18) (NNS -RSB-))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT A) (NN study))
      (VP (VBG using)
        (NP
          (NP (JJ nested) (NN RT-PCR))
          (CC and)
          (NP
            (NP (NNP Southern))
            (VP (VBG blotting)
              (S
                (VP (TO to)
                  (VP (VB detect)
                    (NP
                      (NP (JJ EGFR) (NNS transcripts))
                      (PP (IN in)
                        (NP (NN blood) (NNS samples))))
                    (PP (IN from)
                      (NP
                        (NP (NNS patients))
                        (PP (IN with)
                          (NP (JJ metastatic) (NN colon) (NN cancer)))))))))))))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP
            (NP (CD 10.5) (NN %))
            (PP (IN of)
              (NP (JJ healthy) (NNS donors))))
          (VP (VBD were)
            (ADJP (JJ positive)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBZ suggests)
                    (SBAR (IN that)
                      (S
                        (NP (PRP$ their) (NN assay))
                        (VP (VBD detected)
                          (NP (JJ illegitimate) (NN transcription)))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (NN none))
      (PP (IN of)
        (NP
          (NP (DT the) (CD 27) (JJ PBMNC) (JJ only) (NNS aliquots))
          (VP (VBN tested)
            (PP (IN in)
              (NP (PRP$ our) (NN assay)))))))
    (VP (VBD yielded)
      (NP
        (NP (JJ EGFR) (NN amplification) (NNS products))
        (CC and)
        (NP
          (NP (CD 19/43))
          (PRN (-LRB- -LRB-)
            (NP (CD 44) (NN %))
            (-RRB- -RRB-))
          (SBAR
            (S
              (NP (JJ single) (NN tumor) (NNS cells))
              (VP (VBD were)
                (VP (VBN detected))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT A) (NN comparison))
        (PP (IN of)
          (NP
            (NP (DT the) (NNS results))
            (VP (VBN obtained)
              (PP (IN for)
                (NP
                  (NP (DT the) (CD two) (JJ ER) (JJ positive) (NN cell) (NNS lines))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 6/20))
                    (-RRB- -RRB-))))
              (PP (IN with)
                (NP
                  (NP (DT those))
                  (VP (VBN obtained)
                    (PP (IN for)
                      (NP
                        (NP (DT the) (CD two) (JJ ER) (JJ negative) (NN cell) (NNS lines))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 13/23))
                          (-RRB- -RRB-)))))))))))
      (VP (VBZ suggests)
        (SBAR (IN that)
          (S
            (NP (NNP ER) (NN status))
            (VP (MD will)
              (VP (VB affect)
                (NP
                  (NP (DT the) (NN efficacy))
                  (PP (IN of)
                    (NP (DT this) (NN marker))))))))))
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ remains)
        (NP (DT a) (JJ useful) (NN marker))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Mammaglobin) (CD 1))
      (PRN (-LRB- -LRB-)
        (NP (NNP MGB1))
        (-RRB- -RRB-)))
    (ADVP (RB expression))
    (VP
      (VP (VBZ is)
        (VP (VBN limited)
          (PP (TO to)
            (NP (JJ mammary) (NN epithelium)))))
      (CC and)
      (VP (VBZ is)
        (ADVP (RB often))
        (ADJP (JJ up-regulated)
          (PP (IN in)
            (NP
              (NP (JJ human) (NN breast) (NN cancer))
              (VP (VBG -LSB-)
                (NP (CD 20) (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN gene))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN localised)
          (PP (TO to)
            (NP (NN chromosome) (NNS 11q13)))
          (PP (IN in)
            (NP
              (NP (DT a) (NN region))
              (VP
                (ADVP (RB frequently))
                (VBN amplified)
                (PP (IN in)
                  (NP (NN breast) (NN cancer)))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBG Using)
        (NP (JJ nested) (NN RT-PCR))))
    (, ,)
    (NP (PRP it))
    (VP (VBD was)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (NNP MGB1) (NNS transcripts))
            (VP (VBP are)
              (ADJP (JJ detectable)
                (PP (IN in)
                  (NP (NN blood))))
              (PP (IN from)
                (NP
                  (NP (NN breast) (NN cancer) (NNS patients))
                  (VP (VBG -LSB-)
                    (NP (CD 21) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Marchetti)
        (CC et)
        (NNP al.))
      (, ,)
      (PRN (-LRB- -LRB-)
        (NP (CD 2001))
        (-RRB- -RRB-)))
    (VP
      (VP (VBD analysed)
        (NP (NN lymph) (NNS nodes))
        (PP (IN from)
          (NP
            (NP (NN breast) (NN cancer))
            (CC and)
            (NP (JJ normal) (NNS patients)))))
      (CC and)
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP (NNP MGB1))
            (VP (VBZ is)
              (NP
                (NP (DT a)
                  (ADJP
                    (ADJP (RBR more) (JJ sensitive))
                    (CC and)
                    (ADJP (RBR more) (JJ specific)))
                  (NN RT-PCR) (NN marker))
                (PP (IN than)
                  (NP
                    (NP (DT a) (NN panel))
                    (PP (IN of)
                      (NP
                        (NP (CD six) (JJ other) (NNS markers))
                        (SBAR
                          (WHNP (WDT that))
                          (S
                            (VP (VBD included)
                              (SBAR
                                (S
                                  (NP (NNP CEA) (, ,) (NNP CK19)
                                    (CC and)
                                    (NNP MUC1))
                                  (VP (VBZ -LSB-)
                                    (NP (CD 22) (NNS -RSB-))))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP MGB1) (NNS transcripts))
    (VP (VBD were) (RB not)
      (VP (VBN detected)
        (PP (IN by)
          (NP (PRP us)))
        (PP (IN in)
          (NP
            (NP (DT any))
            (PP (IN of)
              (NP (DT the) (JJ PBMNC) (JJ only) (NNS aliquots)))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (PRP$ our) (NNS hands)))
    (PRN (, ,)
      (S
        (NP (NNP MGB1) (NNS transcripts))
        (VP (VBD were)
          (ADVP (RB only))
          (VP (VBN detected)
            (PP (IN in)
              (NP
                (NP
                  (NP (CD 9/35))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 26) (NN %))
                    (-RRB- -RRB-)))
                (PP (IN of)
                  (NP (DT the) (JJ single) (NN tumor)))))
            (SBAR
              (SBAR
                (S
                  (NP (NNS cells))
                  (VP (VBD tested))))
              (CC but)
              (SBAR (IN because)
                (S
                  (NP (DT this) (NN marker))
                  (VP (VBZ is)
                    (ADJP (JJ mammary-specific)))))))))
      (, ,))
    (NP
      (NP (PRP$ its) (NN inclusion))
      (PP (IN in)
        (NP
          (NP (DT a) (NN panel))
          (PP (IN of)
            (NP (NN RT-PCR) (NNS markers))))))
    (VP (VBZ is)
      (VP (VBN warranted)))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ is)
      (ADJP (JJ possible))
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN sensitivity))
            (PP (IN with)
              (NP (DT this) (NN marker))))
          (VP (MD can)
            (VP (VB be)
              (VP (VBN improved)
                (SBAR (IN if)
                  (S
                    (NP (JJR more) (NN PCR) (NNS cycles))
                    (VP (VBP are)
                      (VP (VBN performed)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP ELF3))
      (, ,)
      (VP
        (ADVP (RB also))
        (VBN known)
        (PP (IN as)
          (NP
            (NP
              (ADJP (JJ Epithelial-Specific)
                (PP (IN with)
                  (NP (JJ serine) (NN bo))))
              (NNP X))
            (PRN (-LRB- -LRB-)
              (NP (NNP ESX))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBZ is)
        (NP
          (NP (DT a) (NN member))
          (PP (IN of)
            (NP
              (NP (DT the) (NNP Ets) (NN multigene) (NN family))
              (PP (IN of)
                (NP (JJ transcriptional) (NNS regulators)))))))
      (CC and)
      (VP (VBZ is)
        (VP (VBN localised)
          (PP (TO to)
            (NP (NN chromosome) (NNS 1q32)))
          (PP (IN in)
            (NP
              (NP (DT a) (NN region))
              (VP (VBN known)
                (S
                  (VP (TO to)
                    (VP (VB be)
                      (VP (VBN amplified)
                        (PP (IN in)
                          (NP
                            (NP (CD 50) (NN %))
                            (PP (IN of)
                              (NP (JJ early) (NN breast) (NNS cancers)))))
                        (S
                          (VP (VBG -LSB-)
                            (NP (CD 11,23) (NNS -RSB-))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (CD ELF3) (NN mRNA) (NN expression))
    (VP (VBZ is)
      (VP (VBN restricted)
        (PP (TO to)
          (NP
            (NP (NNS tissues))
            (PP (IN of)
              (NP (JJ epithelial) (NN origin)))))
        (, ,)
        (PP (VBG including)
          (NP
            (NP
              (ADJP (JJ normal)
                (CC and)
                (JJ malignant))
              (JJ human) (NN mammary) (NN ductal) (NN epithelium))
            (PP (IN with)
              (NP
                (NP (DT no) (NN expression))
                (VP (VBN reported)
                  (PP (IN in)
                    (NP (JJ lympho-haematopoietic) (NNS tissues))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (PRP$ our) (NN assay)))
    (, ,)
    (NP (JJ faint) (NNS bands))
    (VP (VBD were)
      (ADJP (JJ visible)
        (PP (IN at)
          (NP (CD 188) (NN bp))))
      (PP (DT both)
        (PP (IN after)
          (NP
            (NP (CD 45) (NNS cycles))
            (PRN (-LRB- -LRB-)
              (NP (CD 1/6))
              (-RRB- -RRB-))))
        (CC and)
        (PP (IN after)
          (NP
            (NP
              (NP (CD 55) (NNS cycles))
              (PRN (-LRB- -LRB-)
                (NP (CD 5/30))
                (-RRB- -RRB-)))
            (PP (IN in)
              (NP (DT the) (JJ PBMNC) (JJ only) (NNS aliquots)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (NP
      (NP (DT the) (JJ strong) (NN intensity))
      (PP (IN of)
        (NP
          (NP (DT the) (NNS bands))
          (PP (IN for)
            (NP
              (NP (DT the) (NN 40/43)
                (PRN (-LRB- -LRB-)
                  (NP (CD 93) (NN %))
                  (-RRB- -RRB-))
                (NNS samples))
              (PP (IN with)
                (NP (DT a) (JJ single) (NN tumor) (NN cell))))))))
    (VP (VBD was)
      (VP (VBN considered)
        (ADJP (JJ indicative))
        (PP (IN of)
          (NP
            (NP (DT a) (JJ positive) (NN result))
            (PP (IN in)
              (NP (DT these) (NNS cases)))))))
    (. .)))

(ROOT
  (S
    (S
      (S
        (VP (VBG Decreasing)
          (NP (DT the) (NN cycle) (NN number))
          (PP (TO to)
            (NP (CD 35)))))
      (VP
        (VP (VBD eliminated)
          (NP (DT the) (JJ weak) (NN band))
          (PP (IN in)
            (NP (DT the) (JJ PBMNC) (JJ only) (NNS aliquots)))
          (PRN (-LRB- -LRB-)
            (NP (CD 0/15))
            (-RRB- -RRB-)))
        (, ,)
        (CC yet)
        (VP
          (ADVP (RB still))
          (VBD allowed)
          (NP
            (NP (JJ consistent) (NN detection))
            (PP (IN of)
              (NP (DT the) (NN tumor) (NNS cells))))
          (PP (IN in)
            (NP
              (NP (PRP$ our) (NN assay))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 15/16))
                  (: --)
                  (NP (CD 94) (NN %)))
                (-RRB- -RRB-)))))))
    (CC and)
    (S
      (ADVP (RB therefore))
      (NP (NNP ELF3))
      (VP (VBZ is)
        (NP
          (NP (DT a) (JJ useful) (NN marker))
          (PP (IN for)
            (NP
              (NP (NN inclusion))
              (PP (IN in)
                (NP (PRP$ our) (NN panel))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP EphB4))
    (VP
      (VP (VBZ is)
        (NP
          (NP (DT a) (NN member))
          (PP (IN of)
            (NP
              (NP (DT the) (NNP Eph) (NN family))
              (PP (IN of)
                (NP (NN receptor) (NN protein) (NN tyrosine) (NNS kinases)))))))
      (CC and)
      (VP (VBZ has)
        (ADVP (RB recently))
        (VP (VBN been)
          (VP (VBN reported)
            (S
              (VP (TO to)
                (VP (VB be)
                  (VP (VBN up-regulated)
                    (PP (IN in)
                      (NP
                        (NP (NNS cancers))
                        (PP (IN from)
                          (NP (NN prostate) (, ,) (NN breast) (, ,) (NN endometrium) (, ,) (NN lung)
                            (CC and)
                            (NN colon) (NN -LSB-) (JJ 12,24-27) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ is)
      (VP (VBN thought)
        (S
          (VP (TO to)
            (VP (VB play)
              (NP
                (NP
                  (NP (DT an) (JJ important) (NN role))
                  (PP (IN in)
                    (NP (DT the) (NN development))))
                (CC and)
                (NP
                  (NP (NNS oncogenesis))
                  (PP (IN of)
                    (NP (JJ various) (NNS tissues)))))
              (PP (IN through)
                (NP (NNS modifications)))
              (PP (TO to)
                (NP (JJ cell-cell) (NN communication)
                  (CC and)
                  (NN adhesion))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP (NNS EphB4))
        (VP (VBD was)
          (VP (VBN detected)
            (PP (IN in)
              (NP
                (NP (DT some) (NNP PBMNC) (NN cell))
                (VP
                  (ADVP (RB only))
                  (VBZ controls)
                  (PP (IN at)
                    (NP (CD 55) (NNS cycles)))
                  (NP
                    (NP (DT the) (NN level))
                    (PP (IN of)
                      (NP
                        (NP (NN intensity))
                        (PP (IN of)
                          (NP (DT the) (JJ corresponding) (NNS bands))))))
                  (PP (IN on)
                    (NP (JJ agarose) (NNS gels))))))))))
    (VP (VBD was)
      (UCP
        (ADJP (JJ low))
        (CC and)
        (VP (VBG decreasing)
          (NP (DT the) (NN cycle) (NN number))
          (PP (TO to)
            (NP
              (NP (CD 45))
              (VP (VBN resulted)
                (PP (IN in)
                  (NP
                    (NP (DT no) (JJ positive) (NNS samples))
                    (PP (RB out) (IN of)
                      (NP (CD 21) (NNS tests)))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBG Using)
        (NP (JJ EphB4) (JJ specific) (NNS primers))
        (PP (IN with)
          (NP (CD 45) (NNS cycles)))))
    (NP (PRP we))
    (VP (MD could)
      (VP (VB detect)
        (NP
          (NP (CD 77.5) (NN %))
          (PP (IN of)
            (NP
              (NP (JJ single) (NN tumor) (NNS cells))
              (PRN (-LRB- -LRB-)
                (NP (CD 31/40))
                (-RRB- -RRB-)))))
        (S
          (VP (VBG proving)
            (S
              (NP (DT this))
              (VP (TO to)
                (VP (VB be)
                  (NP
                    (NP (DT an) (JJ useful) (NN marker))
                    (PP (IN in)
                      (NP (DT this) (NN assay)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ various) (NNS markers))
      (VP (VBN used)
        (ADVP (RB here))))
    (VP (VBP show)
      (SBAR
        (S
          (NP
            (NP (JJ different) (NNS degrees))
            (PP (IN of)
              (NP (NN heterogeneity))))
          (VP (VBP i.e)
            (NP
              (NP (DT the) (NNS numbers))
              (PP (IN of)
                (NP (JJ single) (NN tumor) (NNS cells))))
            (SBAR (IN that)
              (S
                (NP (PRP they))
                (VP (VBP are)
                  (VP (VBN detected)
                    (PP (IN in))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (X (DT the) (JJR more))
    (NP (JJ heterogeneous) (NNS markers))
    (VP
      (ADVP (RB also))
      (VBD gave)
      (NP
        (NP (DT the)
          (ADJP (JJS least) (JJ false))
          (NNS positives))
        (PP (IN in)
          (NP (DT the) (NNS controls)))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ is)
      (ADJP (JJ unclear))
      (SBAR (IN whether)
        (S
          (NP (DT this))
          (VP (VBZ is)
            (ADJP
              (ADJP (JJ due)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN sensitivity))
                    (PP (IN of)
                      (NP (DT the) (NN test))))))
              (CC or)
              (ADJP (JJ due)
                (PP (TO to)
                  (NP
                    (NP (JJ stochastic) (NNS differences))
                    (PP (IN in)
                      (SBAR (IN whether)
                        (S
                          (NP (DT a) (NN cell))
                          (VP (VBZ expresses)
                            (NP (DT a) (NN transcript))))))))))))
        (CC or)
        (RB not)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Heterogeneity))
      (PP (IN at)
        (NP (DT the) (JJ single) (NN cell) (NN level))))
    (VP (MD must)
      (VP (VB be)
        (VP (VBN taken)
          (PP (IN into)
            (NP (NN account)))
          (SBAR
            (WHADVP (WRB when))
            (S
              (S
                (VP (VBG designing)
                  (NP
                    (NP (DT an) (NN RT-PCR) (NN assay))
                    (CC and)
                    (NP (DT this) (NN study)))))
              (VP (VBZ is)
                (NP (DT the) (JJ first) (NN one)
                  (S
                    (VP (TO to)
                      (VP (VB address)
                        (NP (DT this))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBG Using)
        (NP
          (NP (DT a) (NN panel))
          (PP (IN of)
            (NP (JJ several) (NNS markers))))))
    (VP (MD will)
      (VP (VB reduce)
        (NP
          (NP (DT this) (NN source))
          (PP (IN of)
            (NP (NN error))))))
    (. .)))

(ROOT
  (S
    (NP (DT This))
    (VP (MD can)
      (VP (VB be)
        (VP (VBN seen)
          (PP (IN in)
            (NP (NN table) (CD 3)))
          (SBAR
            (WHADVP (WRB where))
            (S
              (NP (RB nearly) (DT every) (NN tumour) (NN cell))
              (VP (VBZ is)
                (ADJP (JJ positive)
                  (PP (IN for)
                    (NP
                      (QP (JJR more) (IN than) (CD one))
                      (NN marker))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (CD One) (NN T-47D) (NN cell))
      (VP (VBZ is)
        (ADJP (JJ negative)
          (PP (IN for)
            (NP
              (NP (DT all) (CD 5) (NNS markers))
              (VP (VBN tested)))))))
    (CC and)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (ADJP (JJ possible))
        (SBAR (IN that)
          (S
            (NP (DT this) (NN cell))
            (VP (VBD was) (RB not)
              (ADJP (JJ viable)
                (PP (IN at)
                  (NP
                    (NP (DT the) (NN time))
                    (PP (IN of)
                      (NP (NN selection)))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN need)
      (S
        (VP (TO to)
          (VP (VB be)
            (ADJP (DT both) (JJ specific)
              (CC and)
              (JJ sensitive))))))
    (VP (MD may)
      (VP (VB entail)
        (S
          (VP (VBG finding)
            (NP
              (NP (DT a) (NN balance))
              (PP (IN between)
                (NP (DT the) (NN specificity)
                  (CC and)
                  (NN sensitivity))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (PRP$ Our) (NNS findings))
      (PP (IN in)
        (NP (DT the) (NN PBMNC))))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ illegitimate) (NN transcription))
          (VP (VBZ occurs)
            (PP (IN in)
              (NP
                (NP (DT all) (NNS cells))
                (CONJP (RB rather) (IN than))
                (NP (DT a) (NN subset))))))))
    (. .)))

(ROOT
  (S
    (SBAR
      (WHADVP (WRB When))
      (S
        (S
          (NP
            (NP (JJ large) (NNS numbers))
            (PP (IN of)
              (NP (NNS cells))))
          (VP (VBP are)
            (ADJP (JJ present))))
        (CC or)
        (S
          (NP (DT the) (NN assay))
          (VP (VBZ is)
            (ADJP (RB very) (JJ sensitive))))))
    (, ,)
    (NP (JJ false) (NNS positives))
    (VP (MD will)
      (VP (VB be)
        (ADJP (JJ common))))
    (. .)))

(ROOT
  (S
    (NP (NNP ELF3))
    (VP (VBD had)
      (NP
        (NP (DT a)
          (ADJP (RB fairly) (JJ high))
          (JJ false) (JJ positive) (NN rate))
        (PP (IN of)
          (NP (NN amplification))))
      (PP (IN in)
        (NP (NNP PBMNC)))
      (PP (IN at)
        (NP (CD 45) (NNS cycles)))
      (ADVP (RB presumably))
      (S
        (ADJP (JJ due)
          (PP (TO to)
            (S
              (VP (VBG detecting)
                (NP (JJ illegitimate) (NN transcription))
                (PP (IN in)
                  (NP
                    (NP (DT a)
                      (ADJP (RB very) (JJ small))
                      (NN number))
                    (PP (IN of)
                      (NP (DT these) (NNS cells)))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (NNP ELF3))
    (VP (VBD was)
      (NP
        (NP (CD one))
        (PP (IN of)
          (NP
            (NP (DT the)
              (ADJP (RBR more) (JJ robust))
              (NNS markers))
            (VP (VBG giving)
              (NP
                (NP
                  (ADJP (RB very) (JJ strong))
                  (NN amplification))
                (PP (IN of)
                  (NP (JJ single) (NN tumour) (NNS cells))))
              (PP (IN at)
                (NP (CD 45) (NNS cycles))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Amplification))
      (PP (IN from)
        (NP (DT the) (NNS controls))))
    (VP (VBD was)
      (VP (VBN eliminated)
        (SBAR
          (WHADVP (WRB when))
          (S
            (NP
              (NP
                (QP (RB only) (CD 35))
                (NNS cycles))
              (PP (IN of)
                (NP (NN amplification))))
            (VP (VBD were)
              (VP (VBN performed)))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Because)
      (S
        (NP
          (NP (RB only) (DT a) (JJ small) (NN amount))
          (PP (IN of)
            (NP (NN product))))
        (VP (VBD was)
          (VP (VBN amplified)
            (PP (IN after)
              (NP
                (NP (CD 45) (NNS cycles))
                (PP (IN in)
                  (NP (DT these) (NNS controls)))))))))
    (NP (PRP we))
    (VP (MD could)
      (VP (VB distinguish)
        (NP
          (NP (NNS samples))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBD contained)
                (NP
                  (NP (NN tumor) (NNS cells))
                  (CC and)
                  (NP
                    (NP (DT those))
                    (SBAR
                      (WHNP (WDT that))
                      (S
                        (VP (VBD did)
                          (PP (RB not) (IN through)
                            (NP
                              (NP (NN comparison))
                              (PP (IN of)
                                (NP
                                  (NP (DT the) (NN intensity))
                                  (PP (IN of)
                                    (NP (NNS bands))))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT This))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT this))
            (CC and)
            (NP (JJ similar) (NNS markers)))
          (VP (MD will)
            (VP (VB be)
              (ADJP (JJ useful)
                (PP (IN in)
                  (NP (DT a) (JJ real-time) (NNP PCR) (NN methodology))))
              (SBAR
                (WHADVP (WRB where))
                (S
                  (NP (JJ positive) (NNS signals))
                  (VP (MD can)
                    (VP (VB be)
                      (VP
                        (ADVP (RBR more) (RB readily))
                        (VBN differentiated)
                        (PP (IN from)
                          (NP (NN background) (NNS signals)))
                        (S
                          (VP (VBG -LSB-)
                            (NP (CD 15) (NNS -RSB-))))))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN As)
      (S
        (VP (VBD mentioned))))
    (, ,)
    (NP (CD one) (NN question))
    (VP (VBZ is)
      (SBAR (IN whether)
        (S
          (NP (NN cell) (NNS lines))
          (VP (VBP are)
            (ADJP (RB truly) (JJ representative)
              (PP (IN of)
                (S
                  (VP (VBG circulating)
                    (NP (NN tumor) (NNS cells))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT A) (JJ large) (NN number))
      (PP (IN of)
        (S
          (VP (VBG circulating)
            (SBAR
              (S
                (NP (NN tumor) (NNS cells))
                (VP (VBP are)
                  (VP (VBN believed)
                    (S
                      (VP (TO to)
                        (VP (VB be)
                          (PP (IN in)
                            (NP (NNP G0) (NNP -LSB-) (CD 1) (NNS -RSB-)))
                          (, ,)
                          (SBAR (IN whereas)
                            (S
                              (NP (DT the) (NN cell) (NN line) (NNS controls))
                              (VP (VBD used)))))))))))))))
    (VP (VBP are)
      (PP (IN from)
        (NP (NN log) (NN phase) (NNS cells))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD compared)
      (NP
        (NP (DT the) (NN expression))
        (PP (IN of)
          (NP (NNP ELF3) (, ,) (NNP EphB4)
            (CC and)
            (NNP EGFR))))
      (PP (IN in)
        (NP
          (NP (NNS cells))
          (VP (VBN grown)
            (PP (IN under)
              (NP
                (NP (NNS conditions))
                (PP (IN of)
                  (NP (NN serum) (NN starvation)))))
            (, ,)
            (PP
              (PP (IN during)
                (NP (NN log) (NN phase)))
              (CC and)
              (PP (IN at)
                (NP (JJ full) (NN confluence)
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNS data))
                      (VP (RB not) (VBN shown)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD saw)
      (NP (DT no) (JJ appreciable) (NN difference))
      (PP (IN in)
        (NP
          (NP (DT the) (NN expression) (NNS levels))
          (PP (IN of)
            (NP
              (NP (DT any))
              (PP (IN of)
                (NP (DT these) (CD 3) (NNS genes)))))))
      (PP (IN under)
        (NP
          (NP (DT any))
          (PP (IN of)
            (NP
              (NP (DT the) (NNS conditions))
              (VP (VBN tested)))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Whereas)
      (S
        (NP (PRP it))
        (VP (VBZ is)
          (ADJP (JJ difficult)
            (S
              (VP (TO to)
                (VP (VB model)
                  (NP (DT the) (JJ clinical) (NN situation))))))
          (, ,)
          (SBAR
            (WHADVP (WRB where))
            (S
              (NP
                (NP (NNS patterns))
                (PP (IN of)
                  (NP (NN gene) (NN expression))))
              (VP (VBP are)
                (ADJP (JJ likely)
                  (S
                    (VP (TO to)
                      (VP (VB be)
                        (ADJP (JJ heterogeneous))))))))))))
    (, ,)
    (NP
      (NP (DT the) (NN assay))
      (VP (VBN presented)
        (PP (IN in)
          (NP (DT this) (NN communication)))))
    (VP (VBZ is)
      (ADJP (JJ useful)
        (PP
          (PP (IN for)
            (S
              (VP (VBG testing)
                (NP (JJ potential) (NN RT-PCR) (NNS markers)))))
          (CC and)
          (PP (IN as)
            (NP
              (NP (DT a) (JJ meaningful) (NN control))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN determination))
                  (PP (IN of)
                    (NP
                      (NP (DT the) (NN presence))
                      (PP (IN of)
                        (NP
                          (NP (JJ disseminated) (NN tumor) (NNS cells))
                          (PP (IN in)
                            (NP (JJ clinical) (NNS samples))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP
          (ADVP (RB fully))
          (VB validate)
          (NP (DT these) (NNS markers)))))
    (, ,)
    (NP
      (NP (DT a) (JJ clinical) (NN study))
      (VP (VBG using)
        (NP (JJ immunomagnetically) (JJ enriched) (NNS cells))
        (PP (IN from)
          (NP (NNS patients)))))
    (VP (VBZ is)
      (VP (VBN needed)))
    (. .)))

(ROOT
  (S
    (NP (PDT Such) (DT a) (NN study))
    (VP (VBZ is)
      (ADVP (RB currently))
      (PP (IN in)
        (NP (NN progress))))
    (. .)))

(ROOT
  (S
    (NP (NNP Conclusions) (NNP Immunobead) (NNP RT-PCR))
    (VP (VBZ is)
      (NP
        (NP (DT a) (JJ powerful) (NN methodology))
        (PP (IN for)
          (NP
            (NP (DT the) (NN detection))
            (PP (IN of)
              (NP (JJ disseminated) (NN carcinoma) (NNS cells)))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBP need)
      (NP
        (NP (NN RT-PCR) (NNS assays))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP are)
              (ADJP (JJ sensitive) (RB enough)
                (S
                  (VP (TO to)
                    (VP (VB detect)
                      (NP
                        (NP
                          (ADJP (RB very) (JJ low))
                          (NNS numbers))
                        (PP (IN of)
                          (NP (JJ captured) (NN carcinoma) (NNS cells)))
                        (SBAR
                          (S
                            (SBAR (IN As)
                              (S
                                (NP (JJ haematopoietic) (NNS cells))
                                (VP (MD may)
                                  (VP (VB be)
                                    (VP
                                      (ADVP (RB non-specifically))
                                      (VBN retained)
                                      (PP (IN during)
                                        (NP
                                          (NP (JJ immunomagnetic) (NN enrichment))
                                          (PP (IN of)
                                            (NP (JJ epithelial) (NNS cells))))))))))
                            (, ,)
                            (NP (DT these) (NN RT-PCR) (NNS markers))
                            (ADVP (RB also))
                            (VP (VBP need)
                              (S
                                (VP (TO to)
                                  (VP (VB be)
                                    (VP (VBN tested)
                                      (PP (IN for)
                                        (NP (PRP$ their) (NN specificity))))))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT A) (NN set))
      (PP (IN of)
        (NP (NN RT-PCR) (NNS markers))))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN tested)
          (PP (IN for)
            (NP (PRP$ their) (NN ability)
              (S
                (VP (TO to)
                  (VP
                    (VP (VB detect)
                      (NP
                        (NP (DT a) (JJ single) (NN carcinoma) (NN cell))
                        (VP (VBG using)
                          (NP
                            (NP (DT a) (JJ single) (NN round))
                            (PP (IN of)
                              (NP (NNP PCR)))))))
                    (CC and)
                    (VP (VB ethidium)
                      (NP (JJ bromide) (NN visualization)))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBP have)
      (VP (VBN identified)
        (NP
          (NP
            (NP (CD six) (JJ useful) (NNS markers))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VBP include)
                  (NP
                    (NP
                      (NP (DT the)
                        (ADJP (RB previously) (JJ described))
                        (NNS markers))
                      (NP (NNP EpCAM) (, ,) (NNP EGFR) (, ,) (NNP CEA)
                        (CC and)
                        (NNP MGB1)))
                    (CONJP (RB as) (RB well) (IN as))
                    (NP (CD two) (NN novel) (NN markers) (NNS EphB4)))))))
          (, ,)
          (CC and)
          (NP (NNP ELF3)))))
    (. .)))

(ROOT
  (SINV
    (S
      (NP
        (NP (DT This) (NN panel))
        (PP (IN of)
          (NP (NNS markers))))
      (VP (MD should)
        (VP (VB allow)
          (NP
            (NP (DT the) (NN detection))
            (PP (IN of)
              (NP
                (NP (RB virtually) (DT every) (NN tumor) (NN cell))
                (CC and)
                (NP (DT this))))))))
    (VP (VBZ means)
      (SBAR (IN that)
        (S
          (NP (DT a) (JJ positive) (NN result))
          (VP (MD will)
            (VP (VB be)
              (VP (VBN obtained)
                (NP
                  (NP (DT each) (NN time))
                  (SBAR
                    (S
                      (NP (DT an) (JJ immunobead) (NN harvest))
                      (VP (VBZ has)
                        (VP (VBN captured)
                          (ADVP (IN at) (JJS least)))))))))))))
    (NP (CD one) (NN breast) (NN cancer) (NN cell))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJS Most))
      (PP (IN of)
        (NP (DT these) (NNS markers))))
    (VP (MD will)
      (ADVP (RB also))
      (VP (VB be)
        (ADJP (JJ useful)
          (PP (IN in)
            (NP
              (NP (DT the) (NN analysis))
              (PP (IN of)
                (NP
                  (NP (JJ other) (NNS carcinomas))
                  (PP (JJ such) (IN as)
                    (NP (NN colon) (, ,) (NN lung)
                      (CC and)
                      (NN prostate))))))))))
    (. .)))

(ROOT
  (S
    (NP (VBG Competing) (NNS interests) (NNS None))
    (VP (VBD declared))
    (. .)))

(ROOT
  (NP
    (NP
      (NP (JJ Pre-publication) (NN history))
      (SBAR
        (S
          (NP
            (NP (DT The) (JJ pre-publication) (NN history))
            (PP (IN for)
              (NP (DT this) (NN paper))))
          (VP (MD can)
            (VP (VB be)
              (VP (VBN accessed)
                (ADVP (RB here))))))))
    (: :)
    (NP
      (NP (NNP Figure)
        (CC and)
        (NNP Table) (NNS captions))
      (NP (NNP Figure) (CD 1)))
    (: :)
    (NP
      (NP (NNP Expression))
      (PP (IN of)
        (NP
          (NP (CD seven) (NN RT-PCR) (NNS markers))
          (PP (IN in)
            (NP
              (NP (DT a) (NN panel))
              (PP (IN of)
                (NP (CD seven) (JJ breast) (NN cancer) (NN cell) (NNS lines))))))))
    (. .)))

(ROOT
  (S
    (S
      (S
        (NP (DT Each) (NN marker))
        (VP (VBZ is)
          (VP (VBN shown)
            (PP (IN in)
              (NP (DT a) (JJ separate) (NN panel))))))
      (CC and)
      (S
        (NP
          (NP (DT the) (NN size))
          (PP (IN of)
            (NP (DT the) (JJ amplified) (NN product))))
        (VP (VBZ is)
          (VP (VBN indicated)
            (PP (IN in)
              (NP
                (NP (NN base) (NNS pairs))
                (PRN (-LRB- -LRB-)
                  (NP (NN bp))
                  (-RRB- -RRB-))))))))
    (PRN
      (S
        (NP (NNP M))
        (VP (VBZ indicates)
          (NP (DT the) (JJ pUC19/HpaII) (NN marker))))
      (, ,))
    (: -)
    (S
      (NP (NN ve))
      (VP (VBZ indicates)
        (NP (DT the) (JJ RT-PCR) (JJ negative) (NN control))))
    (. .)))

(ROOT
  (S
    (NP (NN Weak) (NN genomic)
      (CC or)
      (NN primer) (NN dimer) (NNS bands))
    (VP (VBP are)
      (VP (VBN seen)
        (PP (IN for)
          (NP (DT some) (NNP RT-PCRs)))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 2))
    (: :)
    (NP
      (NP (NNP Expression))
      (PP (IN of)
        (NP
          (NP (CD seven) (NN RT-PCR) (NNS markers))
          (PP (IN in)
            (NP
              (NP (CD 5) (JJ separate) (JJ single) (NN MDA-MB-453) (NNS cells))
              (VP (VBN lysed)
                (PP (IN with)
                  (NP (CD 100) (JJ normal) (NN PBMNC)))))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Lane) (NNP M))
    (: --)
    (NP (JJ pUC19/HpaII) (JJ molecular) (NN weight) (NN marker))
    (. .)))

(ROOT
  (S
    (NP (DT The) (VBG following) (CD 3) (NNS lanes))
    (VP (VBP are)
      (NP
        (NP (NNS amplifications))
        (PP (IN from)
          (NP (CD 100) (NN PBMNC))))
      (ADVP (RB only)))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT The) (VBG following) (CD 5) (NNS lanes))
      (VP (VBP are)
        (ADJP (JJ amplifications)
          (PP (IN from)
            (NP
              (NP (CD one) (NN MDA-MB-453) (NN cell))
              (PP (IN in)
                (NP (CD 100) (NN PBMNC))))))))
    (, ,)
    (S
      (NP (NNP Lane) (NNP C))
      (VP (VBZ is)
        (NP (DT the) (JJ cDNA) (JJ positive) (NN control))))
    (, ,)
    (S
      (NP (NNP Lane) (NNP G))
      (VP (VBZ is)
        (NP
          (NP (DT the) (JJ genomic) (NN DNA) (NN control))
          (PRN (-LRB- -LRB-)
            (NP (NNP G))
            (-RRB- -RRB-)))))
    (, ,)
    (S
      (NP (NNP Lane) (NNP R))
      (VP (VBZ is)
        (NP (DT the) (NN RT) (: --) (JJ negative) (NN control))))
    (: ;)
    (S
      (NP (NNP Lanes))
      (VP (VBD labelled)
        (SBAR
          (S
            (NP (NNP N))
            (VP (VBP are)
              (NP (DT the) (NNP PCR) (JJ negative) (NNS controls)))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Genomic) (NNS bands))
    (VP (MD can)
      (VP (VB be)
        (VP (VBN seen)
          (PP (IN for)
            (NP (JJ many) (NN ELF3) (NNS amplifications))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 3))
    (: :)
    (NP
      (NP (NNP Expression))
      (PP (IN of)
        (NP
          (NP (CD seven) (NN RT-PCR) (NNS markers))
          (PP (IN in)
            (NP
              (NP (CD 5) (JJ separate) (JJ single) (NN MCF-7) (NNS cells))
              (VP (VBN lysed)
                (PP (IN with)
                  (NP (CD 100) (JJ normal) (NNS MNC)))))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Lane) (NNP M))
    (: --)
    (NP (JJ pUC19/HpaII) (JJ molecular) (NN weight) (NN marker))
    (. .)))

(ROOT
  (S
    (NP (DT The) (VBG following) (CD 3) (NNS lanes))
    (VP (VBP are)
      (NP
        (NP (NNS amplifications))
        (PP (IN from)
          (NP (CD 100) (NN PBMNC))))
      (ADVP (RB only)))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT The) (VBG following) (CD 5) (NNS lanes))
      (VP (VBP are)
        (ADJP (JJ amplifications)
          (PP (IN from)
            (NP
              (NP (CD one) (NN MCF-7) (NN cell))
              (PP (IN in)
                (NP (CD 100) (NN PBMNC))))))))
    (, ,)
    (S
      (NP (NNP Lane) (NNP C))
      (VP (VBZ is)
        (NP (DT the) (JJ cDNA) (JJ positive) (NN control))))
    (, ,)
    (S
      (NP (NNP Lane) (NNP G))
      (VP (VBZ is)
        (NP
          (NP (DT the) (JJ genomic) (NN DNA) (NN control))
          (PRN (-LRB- -LRB-)
            (NP (NNP G))
            (-RRB- -RRB-)))))
    (, ,)
    (S
      (NP (NNP Lane) (NNP R))
      (VP (VBZ is)
        (NP (DT the) (NN RT) (: --) (JJ negative) (NN control))))
    (: ;)
    (S
      (NP (NNP Lanes))
      (VP (VBD labelled)
        (SBAR
          (S
            (NP (NNP N))
            (VP (VBP are)
              (NP (DT the) (NNP PCR) (JJ negative) (NNS controls)))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Genomic) (NNS bands))
    (VP (MD can)
      (VP (VB be)
        (VP (VBN seen)
          (PP (IN for)
            (NP
              (NP
                (NP (JJ many) (NN ELF3) (NNS amplifications))
                (, ,)
                (NP (NNP Table) (CD 1)))
              (: :)
              (NP
                (NP
                  (NP (NNP Primer) (NNS sequences))
                  (-LRB- -LRB-)
                  (NP
                    (NP
                      (NP (NN sense))
                      (PRN (-LRB- -LRB-) (PRP s) (-RRB- -RRB-)))
                    (CC and)
                    (NP
                      (NP (NN anti-sense))
                      (PRN (-LRB- -LRB-)
                        (PP (IN as))
                        (-RRB- -RRB-))))
                  (-RRB- -RRB-))
                (, ,)
                (NP
                  (NP (JJ melting) (NNS temperatures))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Tm))
                    (-RRB- -RRB-))))
              (, ,)
              (NP (VBG annealing) (NN temperature))
              (CC and)
              (NP
                (NP (VBN expected) (NN product) (NN size))
                (PP (IN in)
                  (NP
                    (NP (NNS nucleotides))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP nt))
                      (-RRB- -RRB-))))
                (PP (IN for)
                  (NP
                    (NP (DT each))
                    (PP (IN of)
                      (NP (DT the) (CD seven) (JJ selected) (NN marker) (NNS genes)))))))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Table) (CD 2))
    (: :)
    (NP
      (NP (NNP Comparison))
      (PP (IN of)
        (NP
          (NP (DT the) (NN expression))
          (PP (IN of)
            (NP
              (NP (DT the) (CD seven) (VBN selected) (NNS markers))
              (PP
                (PP (IN in)
                  (CC either)
                  (NP (CD 100) (NNS PBMNCs) (RB only)))
                (, ,)
                (CC or)
                (PP (IN after)
                  (NP
                    (NP (DT the) (NN addition))
                    (PP (IN of)
                      (NP
                        (NP (DT a) (JJ single) (NN tumor) (NN cell))
                        (PP (IN from)
                          (NP (CD one))))))))
              (PP (IN of)
                (NP (CD four) (JJ different) (NN cell) (NNS lines))))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Table) (CD 3))
    (: :)
    (NP
      (NP (NNP Profile))
      (PP (IN of)
        (NP
          (NP (NN gene) (NN expression))
          (PP (IN from)
            (NP
              (NP (CD 10) (JJ different) (NNS experiments))
              (NP (DT each))))))
      (VP (VBG using)
        (NP
          (NP (CD 5) (JJ single) (JJ tumour) (JJ cell/100) (NN PBMNC) (NNS aliquots))
          (PP (IN from)
            (NP (CD four) (JJ different) (NN cell) (NNS lines))))))
    (. .)))

